Table Of Content

Epilepsia, 36(12):1255—1258, 1995 Lippincott—-Raven Publishers, Philadelphia © International League Against Epilepsy Epilepsia Volume 36, 1995 Author Index Aarli JA, 308 Bergstrém M, 712 Coppola G, 1017 Abou-Khalil B, 586, 1065 Bernardi G, 990 Correale JD, 475 Abrey LE, 1237 Berrettini WH, 301 Costelli P, 360 Acharya JN, 429 Beydoun A, 41 Coubes P, 1041 Adkison KDK, 772 Bier M, 290 Couldwell WT, 513, 1237 Airaksinen EM, 276 Blatt I, 508 Crain B, 899 Airaksinen KEJ, 810 Blaxton TA, 733 Crain EF, 334 Akin R, 600 Blume H, 966 Cramer J, 319, 1089, 1111 Alavi A, 722 Bodensteiner J, 783 Cummings LN, 355 Albert P, 1105 Bodian C, 146 Cunningham VJ, 592 Alcalde O, 290 Boire JY, 1041 Curran JG, 873 Alemayehu S, 824 Boisvert D, 798 Cusmai R, 342 Alpay F, 600 Bonanni P, 883 Alvarado S, 966 Borg M, 281 Dailey JW, 911 Amano T, 938 Bourbotte G, 1041 Dakin KA, 494 Amoretti G, 360 Bracht KA, 475 Dalla Bernardina B, 687, 1206 Andermann F, 122 Brewster ME, 255 Dasheiff RM, 508 Andersson J, 712 Brines ML, 371 Davies KG, 130, 1164 Annegers JF, 29, 327, 575 Brockhaus A, 1173 de Boer HM, 957 Annett GM, 1 Brooks DJ, 113, 592 DeGiorgio CM, 475, 842, Antoni G, 712 Brown C, 388 1237 Arac N, 524 Brown MC, 580 de Graaf AS, 219 Arnett JL, 164 Buchtel HA, 1164 de Lanerolle N, 371 Arvela P, 241 Burchfiel J, 671 Delgado MR, 249 Ashwal S. 783 Bureau M, 883 Delisle M-C, 804 Ates N, 86 Burgerman RS, 662 De Murtas M, 990, 997 Avanzini G, 704 Buti D, 687 Desforges C, 1111 Avoli M, 404 Bye AME, 1009 Destafney E, 130 Awad IA, 857 Devinsky O, 851, 1089 Awaya A, 435 Calabresi P, 990, 997 Di Carlo S, 384 Caliskan A, 210 Dichter MA, 526 Bachmann C, 804 Camina F, 471 Dills RL, 772 Bachmann DL, 671 Canevini MP, 1206 Dimpfel W, 983 Bacosi A, 384 Canger R, 1206 Dinner DS, 857 Badarni S, 72 Casazza M, 704 Dodick D, 692 Bailleux V, 559 Cascino GD, 230, 692 Dodrill CB, 164 Baldwin MA, 151 Casetta I, 224 Dogali M, 851 Baldy-Moulinier M, 1041 Castro-Gago M, 471 Doty RL, 531 Baram TZ, 174 Cataltepe O, 396 Dravet C, 883 Barbaro N, | Cendes F, 122 Drury I, 41 Bare MA, 1138 Cereghino JJ, 526 Duché B, 1182 Barkley GL, 1158 Chang Y, 488 Dulac O, 1017 Barron TF, 396 Chatel M, 281 Dumas R, 465 Barry E, 824 Chatterjee SS, 983 Duncan JS, 113, 592, 842 Bartenstein PA, 113 Chelune GJ, 857 Dunham L, 743 Bartolomei F, 48 Chiba S, 410 Diising R, 255 Bass NE, 349 Child R, 1041 Dyck P, 513 Batini C, 101 Chiron C, 1017 Baulac M, 447 Chow S-Y, 196 Ebner A, 207 Baumann RJ, 1003 Christen HJ, 1215 Ediboglu H, 524 Behar KL, 457 Chugani HT, 873 Eeg-Olofsson O, 572 Ben-Aryeh H, 72 Chung HJ, 682 Elger CE, 1173 Ben-Menachem E, 319, 526, Chung M-Y, 488 Erba G, 671 527, 627, 844 Cianchetti C, 687 Ertas H, 524 Benderly A, 72 Cid E, 471 Ertekin C, 524 Beniak TE, 130 Cinzia Monetti V, 224 Eviatar L, 831 Beran RG, 75 Claassen DA, 219 Berg A, 236 Clancy RR, 682 Fadlallah N, 101 Berg AT, 334 Coenen AML, 86 Fakhoury T, 586, 1065 Berg MJ, 671 Colamaria V, 1206 Farrell K, 1025 Berger R, 7 Cole TB, 29 Faught E, 1155 Bergey GK, 824 Connolly MB, 1025 Fazekas F, 946 1255 1256 AUTHOR INDEX FFFeearlzrseabkreia rsg A RGG,,J ,9 8488639 9 HHHaaalamtsoi inreRr H ,GA ,, 7 5815339 7 KKKillvuaiisrns a nDKtJWa, , T1,1 1620487 6 FFFFFFiiiiieonngrrlselrk t oauezMrsErzoEnJei ,,yr T C7NJI31M,,,3 6 ,905 6 326027 1 3 3 HHHHHHaaaaaarnnnsntfiebaiofcoykrekuaatlen ihd n ReW,DnAF, , ,, 9 3A42118-4122 L7141, 5 5 241 KKKKKKoooonotkbne aaaoeDglt b,a e olC Gn ,1,Te 1P G04 ,,573 A9 51 C 65, 6 6 857 FFilsahm inDiR , R,1 113,1 055 92. 1187 HHaauysse rR DW, A,1 08392 7, 334, 575 Kreisman NR, 649 FFFFFFFFFooooolllllnnnlaaeaeznttbnmntiiaeatnai ginrnegn i garaSgnr y,Gn Do B ,Ev3CH, ,KaP6DF 3A-,0,,67 , 8 8 0178J84,0 29 1 042079 75 10 HHHHHHHHHeeeeeeeeerirmrkrnrrtvslszrmajatihoyala e eg annry RTn Y ,RA, DP Y, GB,F2A LB,7,4,7,P2 419 , 1 323 ,499 2 34613 013 7 1,2 64 80, 1089 KKKKKKKKKKiuuuuurrurifnubmibiurtksolsosmeaeetkidvmh l caeaaaoi C nk lB V u,zDH,M HAm, DE ,,Et 1,, ,oA2 87 7 ,1r33715 55n371260 48 4 20 321 0 T4 , 388 Frahm J, 1215 Heydorn WE, 93 Kuzniecky R, 1155 FFrraannzc k D,J E,7 835 43 HHiinrtaoyna maDR ,K , 1,7 5571 3, 1237 Kyllerman M, 216 FFrreeanrc h EJJ,A ,J r.,2 708,2 4 662, 722 HHoircvhahsonlizeemri JAM,, 719125 2 LLaaagteirklauinnde nT DT,J , 669726 FFFFFurrureoejiturieaiekd nbam eYwaa,aVnu , 4 D0A4PG44H, ,7 , 1081489169 HHHHHoouooflnayfzan ebcgrWak ,c YhE,,4 D ,87 U702,8 2 35 51,2 157 63, 929 LLLLaaaaiigk osCY h--mPWH,a,C n 6,a8 4 284 88M 8K , 416 Fujita H, 938 Hulette C, 899 Lammers MW, 440 FFFuuujsjicitowa a rTLa,, 63T44,24 , 7 286,8 7 837, 1084 HHuutmzmleerl R,T , 15719 LLLaaannmggimelerlr tJL,s, m2a9100 2 5A A, 113, 592 Langstrém B, 712 Iannetti P, 423 Lanzkowsky P, 831 GGGGaaaalimlilebmyoab nreedEr eKt,liD l ,a 8C 76A38,A 7, 316202 IIIIIsnsnmhuohpikuiedaekrai aa wtYSaoK,, , 68CT453,,38 7 5 4 4 3253 LLLLLeeeeae cpb hloDanwGQneiP,er,t z5 D8H6,9,N6 2, 49 441761 31 GGaarrannetr DS,S , 1198670 IIssoijmaerrv i A,J IT6,0 03 66, 676, 810 Lee JR-J, 327, 575 GGaeraorfya lGo, E9A6,6 41 ludice A, 687 LLeeee stNm, a 89J9E , 29 GGGiie!bn stKooBnn, JPP1,, 2 40893,3 883 JJaaccko boCwRi,t zJ r.,D M6,9 2 911 LLLeeeirgsniteid ro- JN,A a7,t9 o2l6 i8 2 M, 973 GGGiiiloolavinaangmin olFYi,, 19A12R52,5 704 JJJeaanncssoeebnns JWFAE,,, 569816026 LLLeeetsrtsoyey r- SW,iR lP9,l7 i3g 1 13A8, 447 GGGiniuradoniuacdse a kMtL,,h y43 6555A , 687 JJJooibhmene snoePnzC , FD9,W1 1,6 3 508 LLLeiewveitwsoe vnadD aVhV,l, 86K99,97 1118 Gokcay E, 600 Jokelainen M, 1195 Lilja A, 712 Gokyigit A, 210 Juntunen KTS, 676 Litzinger M, 1078 Gold J, 480 Kamiya Y, 435 Liu H, 249 GGoolrdmeann GMT,, 310115 8 KKaapnegl leHr, P1,2 0934 6 LLooiisseeaauu HP,, 13178 2 GGGGGrroooaevutncolmiondea iern inB ,V J,E,K9, J2 ,2122 22 22454, 2 697 KKKKKeaeaetrtpntautneyreraa nwlmJTay,a,cy ni 1n1n11 2D06L5GB , ,, 787935 1 LLLLLoéouousrbmiicybsnh a gerM rEd, DD ,WW9 C,,0J9 5,4 2 3852 9512,9 763, 929 GGGrrroiooesvsseemrma enr R VR,D, A ,81 30181 51 KKKheioymns seJar,r i3A 7,1 A 4, 403 88 LLLiuuikcdkieaarrns io nHe,Dn , 162O 7,0 ,3 6865 1 GGuuebrerrinmia nR , A4H8,, 878938 KKiinmg JAH,, 279 0 Maher J, 52 GGuuirl leRtC , R, 1077413 KKiirnbgy DS,, 92055 MMaalkaegurt i H.S , 124264 Gustavson LE, 605 Kishi S, 435 Malow B, 733, 1105 Guy NTM, 101 Kitoh H, 435 Mamoli B, 522 Mandelkern M, 388 Epilepsia, Vol. 36, No. 12, 1995 AUTHOR INDEX Mangin J-F, 447 Papageorgiou S, 447 Ronen GM, 52 Manni R, 360 Paris L, 384 Rosenthal E, 72 Marchal C, 37 Parodi C, 360 Ross DA, 1164 Marciani MG, 997 Partanen J, 817 Rothman DL, 457 Mares P, 750 Partanen T, 241 Rottoli A, 1206 Marquez I, 63 Patrick S, 236 Rougier A, 37 Marsh WR, 230, 692 Patsalos PN, 113 Rowan AJ, 270 Mathews G, 586 Pauli E, 79 Matsubayashi H, 938 Pavon P, 471 Sadler RM, 25 Matsuura S, 757 Pédespan J-M, 371182 Saito S, 435 Matthews CD, 75 Peguero E, 586 Salanova V, 16 Mattson RH, 7, 457, 1152 Pelkonen O, 241, 810 Salomon ME, 334 Maxwell RE, 130 Pelzl G, 522 Samson Y, 447 Maytal J, 831 Perrine K, 851, 1089 Sancesario G, 990 McCarthy G, 905 Perrone BL, 649 Sander JWAS, 1187 McLin WM, 957 Perucca E, 627 Sanders PT, 1138 McLoughney J, 75 Petroff OAC, 457 Sasa M, 938 McNutt M, 29 Peyster RG, 93 Sass KJ, 7, 851 Meador K, 1089 Pflaster NL, 943 Satishchandra P, 429 Meinardi H, 440 Philippon J, 447 Sato S, 733 Mengel HB, 605 Pichini S, 384 Savic I, 1225 Merboldt KD, 1215 Pienimaki P, 241 Sayal A, 600 Mercuri NB, 990, 997 Pilke A, 262, 817 Saykin AJ, 662, 1071 Mervaala E, 262, 817 Pillai A, 1126 Schapel GJ, 75 Meyerson LR, 93 Pisani A, 990, 997 Schaul N, 831 Minotti L, 1206 Plouin P, 1017 Scheuer ML, 1131 Miyamoto A, 1161 Pokorny J, 543 Scheyer RD, 522, 1152 Montpied P, 911 Poupaert JH, 559 Schmidt R, 946 Morales A, 349 Pradhan N, 416 Schiiler P, 79 Morrell MJ, 355, 1033 Pranzatelli MR, 783 Schultz L, 174 Morris HH, 16 Prensky AL, 1050 Schulz H-U, 255 Moshé SL, 179, 636, 960, 1203 Prevett MC, 113, 592 Schiirer M, 255 Murata R, 757 Prevost J, 922 Schwartzkroin PA, 543 Murialdo G, 360 Ptachewich Y, 179, 636 Seidenberg M, 137 Murphy CC, 866 Pulliainen V, 1195 Seino M, 728, 837, 1084 Mustonen JN, 810 Punal JE, 471 Seitz RJ, 207 Myllyla VV, 366, 676, 810 Purdy P, 58 Selwa LM, 1164 Pusakulich R, 480 Semah F, 447 Nakai H, 644 Serikawa T, 938 Naquet R, 101 Quatrale R, 224 Sgro V, 1206 Nashef L, 1187 Shafrir Y, 1050 Naugle RI, 857 Rabinowicz AL, 475, 513, Shankar S, 429 Nelson PK, 851 1237 Shapiro ED, 334 Niedermeyer E, 516 Radtke RA, 899 Sharbrough FW, 230, 692 Nishio K, 435 Raffel C, | Shaywitz BA, 270 Noachtar S, 207 Rajput A, 29 Shen DD, 772 Néldner M, 983 Ramsay RE, 580 Shende AC, 831 Notarfrancesco A, 1131 Randolph C, 480 Shewmon DA, 873 Nousiainen U, 262, 817 Rankin G, 480 Shigematsu H, 728, 837 Novelly RA, 7 Rapport RL, 772 Shin C, 692 Raroque HG, Jr., 58 Shinnar S, 179, 334, 636, O’Connor MJ, 662, 722 Raucci U, 423 1203 Oestreich LJ, 671 Rautio A, 810 Shorvon SD, 1187, 1233 Offenbacher H, 946 Reivich M, 722 Shouse MN, 290 Ogunyemi AO, 52 Renier WO, 440, 843 Sidenvall R, 572 Ohtahara S, 658 Repo M, 366 Simpkins F, 388 Ohtsuka Y, 658 Ricci S, 342 Singh A, 798 Ojala M, 1118 Richter A, 255 Siniscalchi A, 404 Ojemann GA, 772 Riekkinen P, 262, 817 Sisodiya SM, 1233 Oka E, 658 Rise M, 63 Skolnick BE, 156 Oki J, 1161 Riva E, 1206 Slater JD, 580 Olivier A, 697 Robain O, 1017 Smith GG, 301 Ortiz J, 636 Robinson LJ, 1071 Smith JR, 892 Osumi AK, 899 Rocca WA, 327, 575 Smith JS, 899 Ozcan O, 600 Rodin E, 1078 Smith SJM, 1233 Rodriguez-Nunez A, 471 Smith TD, 475 Pacifici R, 384, 423 Rodriguez-Segade S, 471 So EL, 230, 692 Pakarinen AJ, 366, 676, 810 Rogawski MA, 566 Solinas GP, 360 Paladin AV, 1058 Roger J, 883 Sommerville KW, 164 Pannell LK, 566 Roine RO, 1241 Soria ED, 736 Paolino E, 224 Roland P, 1225 Spencer DD, 7, 371, 522, 851, Papacostas S, 1131 Rondouin G, 973 905 Epilepsia, Vol. 36, No. 12, 1995 1258 AUTHOR INDEX Spencer SS, 7, 236, 522, 905 Ticku MK, 983 Vigevano F, 342, 687 Sperber EF, 960 Tien RD, 899 Vital A, 37 Sperling M, 682 Tiihonen M, 1118 Vries JK, 508 Sperling MR, 156, 662, 722, Tishler DM, 1 1071 Tokumitsu A, 1161 Wada JA, 410, 1142 Stables JP, 559 Tola MR, 224 Wada Y, 290 Stafiniak P, 1071 Torelli D, 687 Walczak TS, 633, 1131 Stecker MM, 214 Towfighi J, 396 Walker MC, 1233 Stefan H, 79 Trabazo S, 471 Waltimo O, 1118 Stefani A, 990, 997 Treiman DM, 214 Wang Z, 196 Stertz B, 1105 Trenerry MR, 230, 692 Weaver DF, 494 Stollberger R, 946 Trevathan E, 866 Weinand ME, 522 Strelow DC, 230 Tsuchimochi H, 1142 Weinberg KI, | Stiibgen J-P, 316 Tuchman L, 270 West SE, 531 Subramaniam S, 566 Tuomisto L, 276 Westerberg C-E, 712 Sudha S, 416 Tuunainen A, 262, 817 Westerberg G, 712 Suisse G, 281 Westerveld M, 851 Sullivan CM, 270 White S, 1105 Ujihara H, 938 Sum JM, 1033 Wiese HJ, 1003 Uludag B, 524 Sundaresan S, 371 Williams DT, 1131 Uozumi T, 938 Sussman NM, 93, 164, 1111 Williamson PD, 7 Uyakul D, 566 Suzdak PD, 612 Wilson JF, 1003 Swartz BE, 388 Winsky L, 911 Szekeres V, 712 Vachon L, 1111 Witte OW, 207 Szymusiak R, 290 Vahakangas K, 241 Wolf A, 824 Valimaki M, 1118 Wolf SM, 1203 Tabuteau H, 371 Vallée J-P, 559 Wong PKH, 1025 Takahashi S, 1161 Vamecgq J, 559 Wszolek ZK, 108 Takahashi Y, 728, 837, 1084 VanLandingham KE, 899 Wyler AR, 137, 480 Takano K, 644 van Lier H, 440 Wyllie E, 16, 1170 Talwar D, 151 van Luijtelaar ELJM, 86 Tanaka T, 644 Van Ness P, 16 Xu SG, 960 Tancredi V, 404 Vannucci RC, 396 Tanindi S, 600 Van Paesschen W, 146 Yagi K, 728, 837, 1084 Tartara A, 360 Vari RC, 649 Yamaguchi S, 566 Tate E, 783 Varosanec S, 946 Yarrington JT, 93 Tatum WO, 214 Velasco AL, 63 Yeargin-Allsopp M, 866 Tennis P, 29 Velasco F, 63 Yokochi K, 435 Thadani VM, 7 Velasco M, 63 Yonemasu Y, 644 Theodore WH, 733, 1105 Velisiek L, 179, 636 Yusuf FH, 831 Thomas P, 281 Velisikova J, 179, 636 Thompson J, 1078 Verhulst SJ, 349 Zanca M, 1041 Thorell JO, 1225 Vickrey BG, 1089 Zuccaro P, 384, 423 UNITED STATES Statement of Ownership, Management, and Circulation Bead postat service. Requires by Epilepsia, 36(12):1259-1267, 1995 Lippincott—Raven Publishers, Philadelphia © International League Against Epilepsy Subject Index Absence epilepsy. See Epilepsy. Aspartame, and seizure susceptibility, 270 Acetylcholinesterase, carbamazepine effects, 416 Assay, automated, phenytoin, near-patient rapid assay, 1152 ACTH, and neonatal seizures induced by corticotropin-releasing ATPase, Na,K-, hippocampal, in temporal lobe epilepsy, 371 hormone, 174 Atrial natriuretic peptide, in recurrent seizures, 649 ADCI (5-aminocarbonyl-10,1 1-dihydro-SH-dibenzocyclohepten- Auras, olfactory, in epilepsy and temporal lobe resection, 531 5,10-imine) pharmacol-inetics, 566 Adenosine receptors, caffeine and seizure susceptibility, 743 Baboon, cingulate kindling, 1142 Afterdischarges, pentobarbital effects during amygdala kindling, Bay K 8644 in nonconvulsive epilepsy, L-type calcium channel 757 modulation, 86 Age factors Behavior CNS trauma, and acute symptomatic seizures, 327 GABA uptake inhibitor tiagabine effects, 612 complex partial seizures of temporal lobe origin, in children, 1173 gabapentin toxicity, in children, 1203 GABA agents and flurothy] seizures, 636 hypoxia/ischemia effects on bicuculline-induced seizures, 396 GABA, agonist effects in substantia nigra, 960 ictal contralateral paresis in complex partial seizures, 671 verbal memory change after temporal lobectomy, 137 in Northern epilepsy syndrome, 792 Alanine aminotransferase, during vigabatrin treatment, 804 prolonged diffuse spike-wave complex, 210 4-Amino-N-(2,6-dimethylphenyl)phthalimide, comparison with social, and spatial memory, in limbic epilepsy, 973 prototype antiepileptic drugs, 559 Benzodiazepine/GABA, receptors Amnesia binding, in absence seizures, 592 global, after temporal lobectomy, hippocampal cooling, 892 measurement with flumazenil and PET, in absence epilepsy, 113 Tryggve Andersen: Epileptic Hallucinations in the 1890s, Fact Birth cohort, unprovoked seizures, 575 or Fiction?, 308 Blood-brain barrier, valproate unsaturated metabolites, 772 Amobarbital, intracarotid, predictor of memory change after Blood flow, cerebral, in spike-wave discharges, 156 temporal lobectomy, 857 Book Reviews Amygdala. neurocytoma in refractory epilepsy, 1237 The Brainstorms Companion: Epilepsy in our View, 319 Amygdala kindling Epilepsy Explained, 627 effect of kindling of interpeduncular nucleus, 410 The Epilepsy Handbook: The Practical Management of limbic epilepsy, spatial memory and social behavior, 973 Seizures, Second Edition, 526 paroxysmal microarousals, 290 Epileptogenic and Excitotoxic Mechanisms, 526 and pentobarbital effects on entorhinal tetanic responses and Herbal Medicines Used Against Epilepsy in Developing afterdischarges, 757 Countries, 627 sensitivity to adverse effects of antiepileptic drugs, 763 Imitator of Epilepsy, 319 Angelman syndrome, EEG pattern, 1206 Infantile Spasms and West Syndrome, 843 Announcements, 111, 217, 321, 427, 528, 629, 740, 845, 950, An Introduction to Clinical Neurology, Pathophysiology, 1061, 1166 Diagnosis and Treatment, 842 Antiepileptic drugs Medical Dictionary in Six Languages, 527 for absence seizures in tremor rat, 938 Motor Development in Children, 526 carbamazepine. See Carbamazepine. Occipital Seizures and Epilepsies in Children, 216 development of, felbamate monotherapy, 1105 Review of Cerebral SPECT Imaging, 842 intractability, migrating partial seizures, in infants, 1017 Status Epilepticus. Its Clinical Features and Treatment in ion channel-modulating FMRFamide tetrapeptide, 494 Children and Adults, 844 long-term, and thyroid status, 1118 Brain MDRI gene expression in brain, in intractable epilepsy, | acetylcholinesterase and monoamine, carbamazepine effects, monotherapy or polytherapy, 440 416 multiple, dose frequency and dose interval compliance, 1111 calbindin D-28k and calretinin mRNA, in genetically epilepsy- oculogyric crisis with carbamazepine, 1158 prone rats, 911 and ovulatory function in epilepsy, 355 cerebral unilateral heterotopia, and epilepsy, in monozygotic phenytoin, near-patient rapid assay, 1152 twins, 1155 prototype, and 4-amino-N-(2,6-dimethylpheny])phthalimide, cortical dysplasia, nonphotosensitive video game-induced 559 partial seizures, 837 sensitivity to adverse effects, effects of amygdala kindling, cortical lesions, in motor partial seizures and lenticulostriate 763 infarcts, 465 and sudden unexplained death, 29 GABA, glutamate, and glutamine, vigabatrin effects, 457 and tamoxifen interaction, 513 gray or white matter, PLEDS localization, 58 trace elements. glutathione peroxidase, and superoxide injury, neuron-specific enolase after nonconvulsive status dismutase, 609 epilepticus, 475 valproate, magnesium effects in hippocampus, 404 intramyelinic edema induced by vigabatrin, detection by MRI, 93 withdrawal MDRI1 gene expression, in intractable epilepsy, | CNS trauma, and acute symptomatic seizures, 327 mesiotemporal atrophy, delta activity as marker of epileptogenic lateralization of event-related potentials, 262 focus, 122 spectral EEG, 817 MRI and spectroscopy, focal status epilepticus, 946 Antipyrine, and carbamazepine metabolism in placenta, 241 neurocytoma, refractory epilepsy, 1237 Anxiety, self-viewing of seizures, 1138 tumors, high-dose tamoxifen interaction with antiepileptic Aphasia, language before and after temporal lobectomy, 1071 drugs, 513 Appalachia, public attitudes on children with epilepsy, 1003 valproate unsaturated metabolites, 772 Apraxia, acquired epileptiform opercular syndrome, comparison Brainstem, kindling of interpeduncular nucleus, and subsequent with Landau-Kleffner syndrome, 1050 amygdala kindling, 410 1260 SUBJECT INDEX Caffeine, neonatal exposure, and seizure susceptibility in adults, 743 Chromosomal disorders, 4p- syndrome, EEG pattern, 1206 Calbindin D-28k and calretinin mRNA, brain, in genetically Cingulate cortex kindling, in baboon, 1142 epilepsy-prone rats, 911 Circadian rhythm, melatonin release in epilepsy, 75 Calcification, intracerebral, after depth electrode implantation, 508 Classification Calcium absence epilepsies, 1182 channels, L-type modulation in nonconvulsive epilepsy, 86 international, childhood epilepsies, 658 high voltage-activated currents, GP 47779 effects, 997 neocortical temporal lobe epilepsy, 633 Carbamazepine i Clinical trials in epileptic men, 366 aspartame and seizure susceptibility, 270 injectable aqueous, complex with 2-hydroxypropyl-B- felbamate monotherapy, 1105 cyclodextrin, comparison with glycofurol-based, 255 multiple antiepileptic drugs, dose frequency and dose interval and learning, memory, acetylcholinesterase and brain compliance, 1111 monoamines, 416 progressive myoclonus epilepsy, 5-hydroxytryptophan effects, long-term monotherapy, cognitive effects, 1195 783 long-term therapy, and thyroid status, 1118 vigabatrin tolerability in children with refractory partial and menstrual disorders, 676 seizures, 687 neurotoxicity, effects of amygdala kindling on sensitivity to, 763 Clobazam in long-term epilepsy treatment, responders with and oculogyric crisis, 1158 without tolerance, 798 vs. oxcarbazepine, thyroid and myocardial function, 810 Cognitive function placental metabolism, 241 and long-term phenytoin and carbamazepine monotherapy, 119 salivary, in home monitoring, 72 and vigabatrin dosages, 164 and trace elements, glutathione peroxidase, and superoxide Compliance, multiple antiepileptic medications, 1111 dismutase, 600 Computed tomography (CT) Cat, paroxysmal microarousals in amygdala kindling, 290 depth electrode implantation, and intracerebral calcification, 50 Catatonia mimicking nonconvulsive status epilepticus, 943 Northern epilepsy syndrome, 792 Central nervous system trauma, acute symptomatic seizures, 327 PLEDS localization in gray or white matter, 58 Centromedian thalamic nucleus, electric stimulation, 63 Computer screens, photosensitive occipital lobe seizures, 883 Cerebellum, crossed diaschisis, and recurrent focal seizures, 316 Construct validity, quality of life in epilepsy inventory, 1089 Cerebral blood flow, in spike-wave discharges, 156 Convulsions Cerebrospinal fluid (CSF) See also Seizures. histamine, and febrile convulsions, 276 febrile, and histamine in CSF, 276 purine metabolites and pyrimidine bases after febrile febrile, CSF purine metabolites and pyrimidine bases, 471 convulsions, 471 paroxysmal microarousals, in amygdala kindling, 290 Chemosensory event-related potentials, 79 Cooling of hippocampus, global amnesia after temporal Chicken, Fayoumi mutant, development of epilepsy, 101 lobectomy, 892 Children and infants Cortical dysplasia, suppression-bursts in epileptic encephalopathy absence epilepsies, classification, 1182 37 age factors, complex partial seizures of temporal lobe origin, Corticostriatal system, oxcarbazepine metabolite GP 47779 1173 effects, 990, 997 asymmetric hypsarrhythmia, 41 Corticotropin-releasing hormone, neonatal seizures induced by, epilepsy prevalence in 10-year-olds, 866 ACTH effects, 174 epileptic encephalopathy with suppression-bursts and cortical Cytochrome oxidase, hippocampal, in temporal lobe epilepsy, 37 dysplasia, 37 Cytokines in blood mononuclear cells, in epilepsy, 384 epileptic spasms in older children, persistence beyond infancy, 151 Death, sudden unexplained gabapentin toxicity, and behavioral changes, 1203 and learning difficulties in epilepsy, 1187 hemimegalencephaly, 1215 mesial vs. neocortical temporal lobe epilepsy, 662 histamine in CSF, and febrile convulsions, 276 resulting from seizures, 25 identification of localized-onset seizures, 1170 seizures treated with antiepileptic drugs, 29 immune response to vigabatrin treatment, 423 Delta activity in mesiotemporal atrophy, marker of epileptogenic infantile spasms, asymmetric and asy‘ichronous, 873 focus, 122 international classification of childhood epilepsy, 658 Deprenyl deuterium, PET in temporal lobe epilepsy, 712 learning difficulties, and sudden death in epilepsy, 1187 Dermorphin, seizures triggered by, 922 migrating partial seizures, 1017 Deuteranomaly, wavelength specificity in photoparoxysmal neonatal seizures responses, idiopathic generalized epilepsy, 1084 prolactin levels, 682 Development spatial and temporal characteristics, 1009 of epilepsy, in Fayoumi mutant chicken, 101 Northern epilepsy syndrome, 792 flurothyl-induced seizures, MK-801 and phenytoin effects, 179 occipital paroxysmal discharges suppressed by eye opening, 52 migrating partial seizures, in infants, 1017 phenobarbital and phenytoin interactions with carbamazepine, seizure semiology, 1170 249 Developmental disabilities, epilepsy prevalence in 10-year-olds, prolactin, and neonatal seizures, 349 866 public attitudes on epilepsy, 1003 Diaschisis, cerebellar, and focal seizures, 316 reflex myoclonic epilepsy, relation to startle reaction, 342 Diazepam neurotoxicity, effects of amygdala kindling on with refractory partial seizures, vigabatrin tolerability, 687 sensitivity to, 763 salivary carbamazepine, in home monitoring, 72 Dizocilpine binding to ADCI, 566 seizures in acute lymphoblastic leukemia, 831 Dog self-induced photogenic seizures, in myoclonic epilepsy, 728 injectable aqueous carbamazepine, complex with 2- spike complexity, and relative epileptogenicity, 1078 hydroxypropyl-B-cyclodextrin, comparison with trace elements, glutathione peroxidase, and superoxide glycofurol-based, 255 dismutase, in antiepileptic drug therapy, 600 MRI detection of vigabatrin-induced intramyelinic edema in very-low-birthweight infants, incidence of epilepsy, 435 brain, 93 Epilepsia Vol. 36, No. 12, 1995 SUBJECT INDEX Dosage neonatal seizures ADCI, acute and chronic treatment, 566 prolactin role, 349 frequency and interval compliance, multiple antiepileptic drugs, spatial and temporal characteristics, 1009 1111 Northern epilepsy syndrome, 792 monotherapy or polytherapy, 440 occipital lobe epilepsy tiagabine pharmacokinetics, 605 misdiagnosis as migraine, 1233 valproate, daily doses or controlled release preparations, 929 paroxysmal discharges suppressed by eye opening, 52 of vigabatrin, effects on cognitive function and quality of life, opercular myoclonic-anarthric status epilepticus, 281 164 palatal tremor presenting as epilepsia partialis continua, 207 vigabatrin tolerability in children with refractory partial panic attacks seizures, 687 or epilepsy relapse, 48 Drug interactions in parietal lobe seizures, 824 phenobarbital and phenytoin with carbamazepine, in epileptic paroxysmal microarousals, in amygdala kindling, 290 children, 249 prolonged diffuse spike-wave complex, without behavior or tamoxifen and antiepileptic drugs, 513 intellectual changes, 210 Dystonia, in temporal lobe seizures, 1065 psychogenic nonepileptic seizures, outcome analysis, 1131 reflex myoclonic epilepsy, and startle reaction in infants, 342 Echocardiography scalp/sphenoidal, ictal recording, and localization of oxcarbazepine effects, 810 epileptogenic region, 1033 thyroid status, and long-term antiepileptic drugs, 1118 seizures of supplementary sensorimotor area, in children, 1025 Edema, intramyelinic, vigabatrin-induced, detection by MRI, 93 spectral, during discontinuation of antiepileptic drugs in partial Editorials epilepsy, 817 Developmental Aspects of Seizure Semiology: Problems in spike complexity, and relative epileptogenicity, 1078 Identifying Localized-Onset Seizures in Infants and status epilepticus, neuroprotective effects of ketamine, 186 Children, 1170 tremor rat, antiepileptic drugs for absence seizures, 938 Hormonal Changes in Epilepsy, 323 zonisamide effects on kainic acid-induced limbic seizures, 644 Neocortical Temporal Lobe Epilepsy: Characterizing the Electron microscopy, granule cell circuitry in epileptic Syndrome, 633 hippocampus, 543 Public Perceptions About Epilepsy, 957 Electrophysiology Electric stimulation, centromedian thalamic nucleus, 63 familial progressive myoclonus epilepsy, 429 Electrocortiography GP 47779 effects on corticostriatal system, 990, 997 homocysteine-induced seizures, during ontogenesis, 750 granule cell circuitry in epileptic hippocampus, 543 hypoxia/ischemia effects on bicuculline-induced seizures, 396 pentobarbital effects on entorhinal tetanic responses and and temporal lobe epilepsy, relation to MRI and operative afterdischarges during amygdala kindling, 757 outcome, 692 zonisamide effects on kainic acid-induced limbic seizures, 644 Electrodes Emergency medical service depth injury and death from seizures, 25 bilateral hippocampal atrophy in medial temporal lobe propofol in prehospital treatment of convulsive status epilepsy, 905 epilepticus, 1241 and intracerebral calcification, 508 Encephalopathy in temporal lobe epilepsy, 230 epileptic, with suppression-bursts and cortical dysplasia, 37 subdural, hematoma-related seizures, 733 seizures in neonates, prolactin levels, 682 Electroencephalogram (EEG) Entorhinal cortex tetanic responses, pentobarbital effects during acquired epileptiform opercular syndrome, comparison with amygdala Landau-Kleffner syndrome, 1050 kindling, 757 amygdala kindling, effect of kindling of interpeduncular Epidemiology nucleus, 410 acute symptomatic seizures, 327 aspartame and seizure susceptibility, 270 childhood epilepsy, international classification, 658 asymmetric hypsarrhythmia, 41 epilepsy prevaience in 10-year-olds, 866 catatonia mimicking nonconvulsive status epilepticus, 943 ethnic and geographic factors in classic photoparoxysmal cerebral blood flow during spike-wave discharges, 156 response in EEG, 219 classic photoparoxysmal response, ethnic and geographic infantile spasms, 572 factors, 219 risk factors for idiopathic generalized seizures, 224 closed-circuit television, psychogenic elaboration of partial sudden unexplained death, antiepileptic drug treatment, 29 seizures, 1126 unprovoked seizures, secular trends and birth cohort effects, 575 delta activity as marker of epileptogenic focus, in Epilepsia partialis continua, palatal tremor of cortical origin, 207 mesiotemporal atrophy, 122 Epilepsy epilepsy development, in Fayoumi mutant chicken, 101 absence epilepsy prevalence in 10-year-olds, 866 benzodiazepine/GABA, receptors measured with flumazenil epileptic spasms in older children, persistence beyond infancy, and PET, 113 151] classification and prognosis, | 182 after epilepsy surgery, 236 acquired epileptiform opercular syndrome, comparison with false lateralization with FDG PET, in temporal lobe epilepsy, Landau-Kleffner syndrome, 1050 722 carbamazepine treatment, and menstrual disorders, 676 in 4p- syndrome, 1206 and cerebral unilateral heterotopia, in monozygotic twins, 1155 frequency in intracerebral seizures, 697 childhood, international classification, 658 frontal lobe seizures, 16 clobazam in long-term treatment, responders with and without infantile spasms, asymmetric and asynchronous, 873 tolerance, 798 intracranial, and epilepsy surgery, 7 cytokine production in blood mononuclear cells, 384 mesial vs. neocortical temporal lobe epilepsy, 662 development, in Fayoumi mutant chicken, 101 migrating partial seizures, in infants, 1017 encephalopathy with suppression-bursts and cortical dysplasia, motor partial seizures and lenticulostriate infarcts, 465 37 Epilepsia, Vol. 36, No. 12, 1995 1262 SUBJECT INDEX familial progressive myoclonus, 429 Fear, panic attacks in parietal lobe seizures, 824 frontal lobe Febrile seizures FDG-PET sensitivity, 388 CSF purine metabolites and pyrimidine bases, 471 flumazenil PET, 1225 first episode, risk factors, 334 granule cell circuitry in hippocampus, 543 and histamine in CSF, 276 hemimegalencephaly, magnetic resonance spectroscopy, 1215 Felbamate monotherapy, and seizure rate, 1105 hormonal changes, 323 Filters, optical, self-induced photogenic seizures, in myoclonic ictal recording, and localization of epileptogenic region, epilepsy, 728 scalp/sphenoidal EEG, 1033 Flumazenil idiopathic generalized, wavelength specificity in benzodiazepine/GABA, receptors in absence epilepsy, 113 photoparoxysmal responses, 1084 PET, frontal epileptogenic regions, 1225 immune response to vigabatrin treatment, 423 Flurothyl intractable, MDR/ gene expression in brain, | and NBQX block of perinatal hypoxic seizures, 966 learning difficulty, and sudden death, 1187 seizures, age-dependent effects of GABA agents, 636 limbic, spatial memory and social behavior, 973 seizures, MK-801 and phenytoin effects, 179 male hormones, and pituitary function, 360, 366 FMRFamide tetrapeptide, ion channel-modulating, 494 melatonin release, 75 4p- syndrome, EEG pattern, 1206 monotherapy or polytherapy, 440 Frequency analysis, EEG in intracerebral seizures, 697 nonconvulsive, L-type calcium channel modulation, 86 Frontal lobe seizures occipital lobe, misdiagnosis as migraine, 1233 electroclinical syndromes, 16 ovulatory function, 355 Fj FDG-PET sensitivity, 388 partial flumazenil PET, 1225 alanine aminotransferase decrease during vigabatrin of supplementary sensorimotor area, in children, 1025 treatment, 804 spectral EEG during drug discontinuation, 817 GABA (y-aminobutyric acid) phenobarbital and phenytoin interactions with carbamazepine, benzodiazepine/GABA, receptors 249 binding in absence seizures, 592 photosensitive occipital lobe, 883 measurement with flumazenil and PET, 113 prevalence in 10-year-old children, 866 GABA, agonist effects in substantia nigra, age factors, 960 progressive myoclonus, response to 5-hydroxytryptophan, GABA, receptors, losigamone and isomers effects, 983 783 receptors, and flurothyl seizures, age factors, 636 public attitudes, 488, 957, 1003 uptake inhibitor tiagabine quality of life inventory, 1089 neurochemical and behavioral effects, 612 reading, ictal HMPAO-SPECT, 1161 pharmacokinetics of, 605 reflex myoclonic, in infants, relation to startle reaction, 342 vigabatrin effects in brain, 457 refractory, cerebral neurocytoma, 1237 Gabapentin toxicity, behavioral changes in children, 1203 relapse, or panic attacks, 48 Gene expression self-viewing of seizures, 1138 brain calbindin D-28k and calretinin mRNA, in genetically spasms, in older children, persistence beyond infancy, 151 epilepsy-prone rats, 911 status epilepticus. See Status epilepticus. MDR1, in brain, in intractable epilepsy, | surgery. See Lobectomy, temporal; Neurosurgery. Surgery Genetics without intracranial EEG, 7 epidemiology of infantile spasms, 572 temporal lobe epilepsy development, in Fayoumi mutant chicken, 101 chemosensory event-related potentials, 79 familial progressive myoclonus epilepsy, 429 depth electrodes, 230 Northern epilepsy syndrome, 792 electrocortiography, relation to MRI and operative outcome, risk factors for idiopathic generalized seizures, 224 692 tiagabine effects, 612 false lateralization with FDG PET, 722 Geographic factors, in classic photoparoxysmal response in EEG, ipsilateral head turning and dystonia, 1065 219 medial, bilateral hippocampal atrophy, 905 Geometry optimization, ion channel-modulating FMRFamide PET with deuterium-deprenyl, 712 tetrapeptide, 494 resection, effect on olfactory function, 531 Gliosis visual learning, selective reminding and delayed recall, 704 hemimegalencephaly, 1215 in twentieth century literature, 1058 PET with deuterium-deprenyl, in temporal lobe epilepsy, 712 valproate treatment, daily doses or controlled release Glossopharyngeal muscles, opercular myoclonic-anarthric status preparations, 929 epilepticus, 281 in very-low-birthweight infants, 435 Glutamate vigabatrin dosage effects on cognitive function and quality of and unit discharges in CA1 area of hippocampus, 196 life, 164 vigabatrin effects in brain, 457 Erratum, Physiologic and Morphologic Characteristics of Granule Glutamine, vigabatrin effects in brain, 457 Cell Circuitry in Human Epileptic Hippocampus, 1064 Glutathione peroxidase, and antiepileptic drug therapy, 600 Estrogens Gonadotropins in epileptic men, 360 carbamazepine treatment, and menstrual disorders, 676 GP 47779 in epilepsy, 323 and corticostriatal synaptic transmission, 990 Ethnic factors, classic photoparoxysmal response in EEG, 219 and high voltage-activated calcium currents, 997 Event-related potentials Granule cell circuitry, in epileptic hippocampus, 543 auditory, lateralization during discontinuation of antiepileptic medication, 262 Hallucinations, Tryggve Andersen: Epileptic Hallucinations in the chemosensory, in temporal lobe epilepsy, 79 1890s, Fact or Fiction?, 308 Eye opening, and occipital paroxysmal discharges, 52 Head injuries, from seizures, 25 Head turning, ipsilateral, and dystonia, in temporal lobe seizures, Family history, risk factor for first febrile seizure, 334 1065 Epilepsia, Vol. 36, No. 12, 1995 SUBJECT INDEX Health Surveys Kainic acid public attitudes on children with epilepsy, 1003 limbic epilepsy, spatial memory and social behavior, 973 quality ofl ife in epilepsy inventory, 1089 limbic seizures, zonisamide effects, 644 Hematoma seizures, during subdural electrode monitoring, 733 seizure susceptibility, in DBA/2J and C57BL/6J mice, 301 Hemimegalencephaly, magnetic resonance spectroscopy, 1215 Ketamine, neuroprotective effects, in status epilepticus, 186 Heterotopia, cerebral unilateral, and epilepsy, in monozygotic Kidney failure twins, 1155 in HIV infections, and new-onset seizures, 146 High performance liquid chromatography with recurrent seizures, 649 carbamazepine metabolism in placenta, 241 Kindling histamine in CSF, and febrile convulsions, 276 amygdala Hippocampus paroxysmal microarousals, 290 anticonvulsant effects of valproate, magnesium role, 404 pentobarbital effects on entorhinal tetanic responses and bilateral atrophy, in medial temporal lobe epilepsy, 905 afterdischarges, 757 epileptic, granule cell circuitry, 543 sensitivity to adverse effects of antiepileptic drugs, 763 fast spin-echo MRI, neuronal density in temporal lobectomy cingulate cortex, in baboon, 1142 patients, 899 interpeduncular nucleus, and subsequent amygdala kindling, 410 Na,K-ATPase, cytochrome oxidase, and total protein, in temporal lobe epilepsy, 371 Lafora disease, 5-hydroxytryptophan effects, 783 thermal inactivation, and global amnesia after temporal Landau-Kleffner syndrome, comparison with acquired lobectomy, 892 epileptiform opercular syndrome, 1050 unit discharges in CA1 area, effects of glutamate, NMDA, Language potassium, and hypoxia, 196 after temporal lobectomy without mapping of cortical function, Histamine in CSF, and febrile convulsions, 276 130 Histochemistry before and after temporal lobectomy, 1071 granule cell circuitry, in epileptic hippocampus, 543 Lateralization hippocampal Na,K-ATPase, cytochrome oxidase, and total false, FDG PET of temporal lobe epilepsy, 722 protein, in temporal lobe epilepsy, 371 seizures, and Wada test memory disparities, 851 Historical Notes Learning The Medical-Moral Account on Epilepsy by Pedro de Horta: carbamazepine effects, 416 A Historical Review, 736 difficulties, and sudden death in epilepsy, 1187 Tryggve Andersen: Epileptic Hallucinations in the 1890s, Fact visual, selective reminding and delayed recall, in temporal lobe or Fiction?, 308 epilepsy, 704 Homocysteine seizures, during ontogenesis, 750 Lenticulostriate infarcts, motor partial seizures, 465 Hormones Letters to the Editor, 214, 522, 524; 1164 in epilepsy, 323, 355 Leukemia, lymphoblastic, seizure treatment, 831 male, and pituitary function in epilepsy, 360, 366 Limbic system, epilepsy and temporal lobe resection, effects on and olfactory function in epilepsy, 531 olfactory function, 531 Human immunodeficiency virus (HIV) infections, new-onset Literature seizures and metabolic abnormalities, 146 Tryggve Andersen: Epileptic Hallucinations in the 1890s, Fact 2-Hydroxypropyl-B-cyclodextrin, carbamazepine complex, or Fiction?, 308 tolerability and pharmacokinetics, 255 twentieth century, epilepsy portrayals, 1058 5-Hydroxytryptophan, in progressive myoclonus epilepsy, 783 Lobectomy, temporal Hypersomnolence, episodic, due to seizures, 108 age factors in verbal memory changes, 137 Hypothalamopituitary axis, in epilepsy, 323 fast spin-echo MRI of hippocampal volume, 899 Hypoxia global amnesia, and hippocampal cooling, 892 and ischemia, bicuculline-induced seizures, behavioral and intracarotid amobarbital as predictor of memory change, 857 electrocortical effects, 396 language before and after, 1071 perinatal seizures, NBQX block of, 966 lateralization of event-related potentials during drug and unit discharges in CA1 area of hippocampus, 196 discontinuation, 262 Hypsarrhythmia, asymmetric, EEG and radiology, 41 and olfactory function, 531 without stimulation mapping, language function, 130 Ictal recording Wechsler Adult Intelligence Scale-Revised in evaluation, 480 and localization of epileptogenic region, scalp/sphenoidal EEG, Losigamone and isomers, effects on GABA, receptors, 983 1033 Luteinizing hormone in epileptic men, 360 SPECT, in reading epilepsy, 1161 Immune response, vigabatrin treatment in epileptic children, Magnesium 423 extracellular, and valproate effects in hippocampus, 404 Immunoassay, phenytoin, near-patient rapid assay, 1152 in HIV infections, and new-onset seizures, 146 Incontinence, in psychogenic seizures, 586 Magnetic resonance imaging (MRI) Infections, HIV, new-onset seizures and metabolic abnormalities, bilateral hippocampal atrophy in medial temporal lobe epilepsy, 146 905 Infertility, ovulatory function in epilepsy, 355 crossed cerebellar diaschisis, and recurrent focal seizures, 316 Injury delta activity as marker of epileptogenic focus, in and death, from seizures, 25 mesiotemporal sclerosis, 122 self-inflicted, in psychogenic seizures, 586 depth electrodes in temporal lobe epilepsy, 230 Intellectual factors, prolonged diffuse spike-wave complex, and electrocortiography, in temporal lobe epilepsy, 692 210 epileptic encephalopathy, with suppression-bursts and cortical Interleukins in blood mononuclear cells, in epilepsy, 384 dysplasia, 37 Ischemia fast spin-echo, hippocampal volume, neuronal density in in bicuculline-induced seizures, behavioral and electrocortical temporal lobectomy patients, 899 effects, 396 of focal status epilepticus, 946 tiagabine effects, 612 frontal lobe epilepsy, FDG-PET sensitivity, 388 Epilepsia, Vol. 36, No. 12, 1995 1264 SUBJECT INDEX hemimegalencephaly, 1215 NBQX, and perinatal hypoxic seizures, 966 panic attacks in parietal lobe seizures, 824 Neocortical temporal lobe epilepsy PLEDS localization in gray or white matter, 58 characterization of syndrome, 633 temporal interictal hypometabolism and mesial sclerosis, 447 vs. mesial, 662 temporal lobectomy without EEG, 7 Neurocytoma, cerebral, refractory epilepsy, 1237 vigabatrin effects on GABA, glutamate, and glutamine in brain, Neuroimaging 457 asymmetric hypsarrhythmia, 41 vigabatrin-induced intramyelinic edema in brain, 93 PLEDS localization in gray or white matter, 58 Mapping, stimulation, in temporal lobectomy, language function, Neuron-specific enolase, after nonconvulsive status epilepticus, 130 475 MDRI! gene expression, in brain, in intractable epilepsy, | Neuronal density in temporal lobectomy, fast spin-echo MRI of Melatonin in active epilepsy, 75 hippocampal volume, 899 In Memoriam, A.Earl Walker: Neurosurgeon, Neuroscientist, and Neuroprotection by ketamine, in status epilepticus, 186 Epileptologist, 516 Neuropsychology Memory age factors in verbal memory changes after temporal lobectomy, carbamazepine effects, 416 137 global amnesia after temporal lobectomy, hippocampal cooling, cognitive effects of long-term phenytoin and carbamazepine 892 monotherapy, 1195 material-specific, intracarotid amobarbital as predictor after language before and after temporal lobectomy, 1071 temporal lobectomy, 857 language function after temporal lobectomy without stimulation spatial, and social behavior, in limbic epilepsy, 973 mapping, 130 verbal, after temporal lobectomy, age factors, 137 nonphotosensitive video game-induced partial seizures, 837 visual learning, selective reminding and delayed recall, in pseudoseizures, induction by intravenous saline, 580 temporal lobe epilepsy, 704 quality of life in epilepsy inventory, 1089 Wada test disparities, and seizure laterality and postoperative temporal lobectomy without EEG, 7 seizure control, 851 Wechsler Adult Intelligence Scale-Revised in evaluation for Mensicual disorders, and carbamazepine, 676 temporal lobectomy, 480 Mental deterioration, Northern epilepsy syndrome, 792 Neurosurgery Mesiotemporal sclerosis See also Lobectomy, temporal delta activity as marker of epileptogenic focus, 122 depth electrode implantation EEG and seizure outcome after epilepsy surgery, 236 and intracerebral calcification, 508 vs. neocortical temporal lobe epilepsy, 662 in temporal lobe epilepsy, 230 and temporal interictal hypometabolism, 447 EEG and seizure outcome, 236 Message from the Editor, 955 and electrocortiography, in temporal lobe epilepsy, 692 Metabolism epileptic encephalopathy with suppression-bursts and cortical and new-onset seizures in HIV infections, 146 dysplasia, 37 temporal interictal hypometabolism and mesial sclerosis, 447 for frontal lobe seizures, 16 Methohexital distribution monitored with HMPAO, SPECT during global amnesia after temporal lobectomy, hippocampal cooling, Wada test, 1041 892 N-Methyl-D-aspartate (NMDA), and unit discharges in CAI area mesial vs. neocortical temporal lobe epilepsy, 662 of hippocampus, 196 seizure laterality, and Wada test memory disparities, 851 Migraine, misdiagnosis of occipital lobe epilepsy, 1233 temporal lobe resection, and olfactory function, 531 Mitochondrial encephalomyopathy, 5-hydroxytryptophan effects, temporal lobectomy without EEG, 7 783 Neurotoxicity MK-801 4-amino-N-(2,6-dimethylphenyl)phthalimide, comparison with and flurothyl-induced seizures during development, 179 prototype antiepileptic drugs, 559 and NBQX block of perinatal hypoxic seizures, 966 of antiepileptic drugs, effects of amygdala kindling on Molecular conformation, ion channel-modulating FMRFamide sensitivity to, 763 tetrapeptide, 494 GABA uptake inhibitor tiagabine, 612 Monitoring, home, of carbamazepine, in saliva, 72 gabapentin, behavioral changes in children, 1203 Monoamines, brain, carbamazepine effects, 416 monotherapy or polytherapy of antiepileptic drugs, 440 Mononuclear cells, blood, cytokine production, 384 Neurotoxins, focal seizures, and crossed cerebellar diaschisis, Morbidity, very-low-birthweight infants, incidence of epilepsy, 43 5 316 Mossy fibers, granule cell circuitry in epileptic hippocampus, 54 3mi Northern epilepsy syndrome, clinical course and medication Mouse effects, 792 ADCI pharmacokinetics, 566 4-amino-N-(2,6- Nucieus, centromedian thalamic, electric stimulation, 63 dimethylphenyl)phthalimide, comparison with prototype antiepileptic drugs, 559 Occipital lobe epilepsy audiogenic seizure, unit discharges in CA1 area of misdiagnosis as migraine, 1233 hippocampus, effects of glutamate, NMDA, potassium, and paroxysmal discharges suppressed by eye opening, 52 hypoxia, 196 photosensitive, 883 DBA/2J and C57BL/6J, seizure susceptibility induced by kainic Oculogyric crisis with carbamazepine, 1158 acid, 301 Ohtahara syndrome, suppression-bursts in epileptic Muscimol, GABA, agonist effects in substantia nigra, age factors, encephalopathy, 37 960 Olfaction Myocardial function, oxcarbazepine effects, 810 chemosensory event-related potentials, in temporal lobe Myoclonus epilepsy, 79 familial progressive epilepsy, 429 epilepsy and temporal lobe resection, 531 4p- syndrome, EEG pattern, 1206 Ontogeny progressive epilepsy, response to 5-hydroxytryptophan, 783 homocysteine-induced seizures, 750 reflex epilepsy, and startle reaction in infants, 342 seizure susceptibility in adults, neonatal caffeine exposure, 743 self-induced photogenic seizures, in infancy, 728 Opercular myoclonic-anarthric status epilepticus, case reports, 281 Epilepsia, Vol. 36, No. 12, 1995

ebook img

Epilepsia 1995: Vol 36 Index PDF

13 Pages·1995·3.3 MB·English
by  
#periodicals #sim_microfilm #pub_epilepsia
Save to my drive
Quick download
Download
Upgrade Premium
Most books are stored in the elastic cloud where traffic is expensive. For this reason, we have a limit on daily download.

Preview Epilepsia 1995: Vol 36 Index

Epilepsia, 36(12):1255—1258, 1995 Lippincott—-Raven Publishers, Philadelphia © International League Against Epilepsy Epilepsia Volume 36, 1995 Author Index Aarli JA, 308 Bergstrém M, 712 Coppola G, 1017 Abou-Khalil B, 586, 1065 Bernardi G, 990 Correale JD, 475 Abrey LE, 1237 Berrettini WH, 301 Costelli P, 360 Acharya JN, 429 Beydoun A, 41 Coubes P, 1041 Adkison KDK, 772 Bier M, 290 Couldwell WT, 513, 1237 Airaksinen EM, 276 Blatt I, 508 Crain B, 899 Airaksinen KEJ, 810 Blaxton TA, 733 Crain EF, 334 Akin R, 600 Blume H, 966 Cramer J, 319, 1089, 1111 Alavi A, 722 Bodensteiner J, 783 Cummings LN, 355 Albert P, 1105 Bodian C, 146 Cunningham VJ, 592 Alcalde O, 290 Boire JY, 1041 Curran JG, 873 Alemayehu S, 824 Boisvert D, 798 Cusmai R, 342 Alpay F, 600 Bonanni P, 883 Alvarado S, 966 Borg M, 281 Dailey JW, 911 Amano T, 938 Bourbotte G, 1041 Dakin KA, 494 Amoretti G, 360 Bracht KA, 475 Dalla Bernardina B, 687, 1206 Andermann F, 122 Brewster ME, 255 Dasheiff RM, 508 Andersson J, 712 Brines ML, 371 Davies KG, 130, 1164 Annegers JF, 29, 327, 575 Brockhaus A, 1173 de Boer HM, 957 Annett GM, 1 Brooks DJ, 113, 592 DeGiorgio CM, 475, 842, Antoni G, 712 Brown C, 388 1237 Arac N, 524 Brown MC, 580 de Graaf AS, 219 Arnett JL, 164 Buchtel HA, 1164 de Lanerolle N, 371 Arvela P, 241 Burchfiel J, 671 Delgado MR, 249 Ashwal S. 783 Bureau M, 883 Delisle M-C, 804 Ates N, 86 Burgerman RS, 662 De Murtas M, 990, 997 Avanzini G, 704 Buti D, 687 Desforges C, 1111 Avoli M, 404 Bye AME, 1009 Destafney E, 130 Awad IA, 857 Devinsky O, 851, 1089 Awaya A, 435 Calabresi P, 990, 997 Di Carlo S, 384 Caliskan A, 210 Dichter MA, 526 Bachmann C, 804 Camina F, 471 Dills RL, 772 Bachmann DL, 671 Canevini MP, 1206 Dimpfel W, 983 Bacosi A, 384 Canger R, 1206 Dinner DS, 857 Badarni S, 72 Casazza M, 704 Dodick D, 692 Bailleux V, 559 Cascino GD, 230, 692 Dodrill CB, 164 Baldwin MA, 151 Casetta I, 224 Dogali M, 851 Baldy-Moulinier M, 1041 Castro-Gago M, 471 Doty RL, 531 Baram TZ, 174 Cataltepe O, 396 Dravet C, 883 Barbaro N, | Cendes F, 122 Drury I, 41 Bare MA, 1138 Cereghino JJ, 526 Duché B, 1182 Barkley GL, 1158 Chang Y, 488 Dulac O, 1017 Barron TF, 396 Chatel M, 281 Dumas R, 465 Barry E, 824 Chatterjee SS, 983 Duncan JS, 113, 592, 842 Bartenstein PA, 113 Chelune GJ, 857 Dunham L, 743 Bartolomei F, 48 Chiba S, 410 Diising R, 255 Bass NE, 349 Child R, 1041 Dyck P, 513 Batini C, 101 Chiron C, 1017 Baulac M, 447 Chow S-Y, 196 Ebner A, 207 Baumann RJ, 1003 Christen HJ, 1215 Ediboglu H, 524 Behar KL, 457 Chugani HT, 873 Eeg-Olofsson O, 572 Ben-Aryeh H, 72 Chung HJ, 682 Elger CE, 1173 Ben-Menachem E, 319, 526, Chung M-Y, 488 Erba G, 671 527, 627, 844 Cianchetti C, 687 Ertas H, 524 Benderly A, 72 Cid E, 471 Ertekin C, 524 Beniak TE, 130 Cinzia Monetti V, 224 Eviatar L, 831 Beran RG, 75 Claassen DA, 219 Berg A, 236 Clancy RR, 682 Fadlallah N, 101 Berg AT, 334 Coenen AML, 86 Fakhoury T, 586, 1065 Berg MJ, 671 Colamaria V, 1206 Farrell K, 1025 Berger R, 7 Cole TB, 29 Faught E, 1155 Bergey GK, 824 Connolly MB, 1025 Fazekas F, 946 1255 1256 AUTHOR INDEX FFFeearlzrseabkreia rsg A RGG,,J ,9 8488639 9 HHHaaalamtsoi inreRr H ,GA ,, 7 5815339 7 KKKillvuaiisrns a nDKtJWa, , T1,1 1620487 6 FFFFFFiiiiieonngrrlselrk t oauezMrsErzoEnJei ,,yr T C7NJI31M,,,3 6 ,905 6 326027 1 3 3 HHHHHHaaaaaarnnnsntfiebaiofcoykrekuaatlen ihd n ReW,DnAF, , ,, 9 3A42118-4122 L7141, 5 5 241 KKKKKKoooonotkbne aaaoeDglt b,a e olC Gn ,1,Te 1P G04 ,,573 A9 51 C 65, 6 6 857 FFilsahm inDiR , R,1 113,1 055 92. 1187 HHaauysse rR DW, A,1 08392 7, 334, 575 Kreisman NR, 649 FFFFFFFFFooooolllllnnnlaaeaeznttbnmntiiaeatnai ginrnegn i garaSgnr y,Gn Do B ,Ev3CH, ,KaP6DF 3A-,0,,67 , 8 8 0178J84,0 29 1 042079 75 10 HHHHHHHHHeeeeeeeeerirmrkrnrrtvslszrmajatihoyala e eg annry RTn Y ,RA, DP Y, GB,F2A LB,7,4,7,P2 419 , 1 323 ,499 2 34613 013 7 1,2 64 80, 1089 KKKKKKKKKKiuuuuurrurifnubmibiurtksolsosmeaeetkidvmh l caeaaaoi C nk lB V u,zDH,M HAm, DE ,,Et 1,, ,oA2 87 7 ,1r33715 55n371260 48 4 20 321 0 T4 , 388 Frahm J, 1215 Heydorn WE, 93 Kuzniecky R, 1155 FFrraannzc k D,J E,7 835 43 HHiinrtaoyna maDR ,K , 1,7 5571 3, 1237 Kyllerman M, 216 FFrreeanrc h EJJ,A ,J r.,2 708,2 4 662, 722 HHoircvhahsonlizeemri JAM,, 719125 2 LLaaagteirklauinnde nT DT,J , 669726 FFFFFurrureoejiturieaiekd nbam eYwaa,aVnu , 4 D0A4PG44H, ,7 , 1081489169 HHHHHoouooflnayfzan ebcgrWak ,c YhE,,4 D ,87 U702,8 2 35 51,2 157 63, 929 LLLLaaaaiigk osCY h--mPWH,a,C n 6,a8 4 284 88M 8K , 416 Fujita H, 938 Hulette C, 899 Lammers MW, 440 FFFuuujsjicitowa a rTLa,, 63T44,24 , 7 286,8 7 837, 1084 HHuutmzmleerl R,T , 15719 LLLaaannmggimelerlr tJL,s, m2a9100 2 5A A, 113, 592 Langstrém B, 712 Iannetti P, 423 Lanzkowsky P, 831 GGGGaaaalimlilebmyoab nreedEr eKt,liD l ,a 8C 76A38,A 7, 316202 IIIIIsnsnmhuohpikuiedaekrai aa wtYSaoK,, , 68CT453,,38 7 5 4 4 3253 LLLLLeeeeae cpb hloDanwGQneiP,er,t z5 D8H6,9,N6 2, 49 441761 31 GGaarrannetr DS,S , 1198670 IIssoijmaerrv i A,J IT6,0 03 66, 676, 810 Lee JR-J, 327, 575 GGaeraorfya lGo, E9A6,6 41 ludice A, 687 LLeeee stNm, a 89J9E , 29 GGGiie!bn stKooBnn, JPP1,, 2 40893,3 883 JJaaccko boCwRi,t zJ r.,D M6,9 2 911 LLLeeeirgsniteid ro- JN,A a7,t9 o2l6 i8 2 M, 973 GGGiiiloolavinaangmin olFYi,, 19A12R52,5 704 JJJeaanncssoeebnns JWFAE,,, 569816026 LLLeeetsrtsoyey r- SW,iR lP9,l7 i3g 1 13A8, 447 GGGiniuradoniuacdse a kMtL,,h y43 6555A , 687 JJJooibhmene snoePnzC , FD9,W1 1,6 3 508 LLLeiewveitwsoe vnadD aVhV,l, 86K99,97 1118 Gokcay E, 600 Jokelainen M, 1195 Lilja A, 712 Gokyigit A, 210 Juntunen KTS, 676 Litzinger M, 1078 Gold J, 480 Kamiya Y, 435 Liu H, 249 GGoolrdmeann GMT,, 310115 8 KKaapnegl leHr, P1,2 0934 6 LLooiisseeaauu HP,, 13178 2 GGGGGrroooaevutncolmiondea iern inB ,V J,E,K9, J2 ,2122 22 22454, 2 697 KKKKKeaeaetrtpntautneyreraa nwlmJTay,a,cy ni 1n1n11 2D06L5GB , ,, 787935 1 LLLLLoéouousrbmiicybsnh a gerM rEd, DD ,WW9 C,,0J9 5,4 2 3852 9512,9 763, 929 GGGrrroiooesvsseemrma enr R VR,D, A ,81 30181 51 KKKheioymns seJar,r i3A 7,1 A 4, 403 88 LLLiuuikcdkieaarrns io nHe,Dn , 162O 7,0 ,3 6865 1 GGuuebrerrinmia nR , A4H8,, 878938 KKiinmg JAH,, 279 0 Maher J, 52 GGuuirl leRtC , R, 1077413 KKiirnbgy DS,, 92055 MMaalkaegurt i H.S , 124264 Gustavson LE, 605 Kishi S, 435 Malow B, 733, 1105 Guy NTM, 101 Kitoh H, 435 Mamoli B, 522 Mandelkern M, 388 Epilepsia, Vol. 36, No. 12, 1995 AUTHOR INDEX Mangin J-F, 447 Papageorgiou S, 447 Ronen GM, 52 Manni R, 360 Paris L, 384 Rosenthal E, 72 Marchal C, 37 Parodi C, 360 Ross DA, 1164 Marciani MG, 997 Partanen J, 817 Rothman DL, 457 Mares P, 750 Partanen T, 241 Rottoli A, 1206 Marquez I, 63 Patrick S, 236 Rougier A, 37 Marsh WR, 230, 692 Patsalos PN, 113 Rowan AJ, 270 Mathews G, 586 Pauli E, 79 Matsubayashi H, 938 Pavon P, 471 Sadler RM, 25 Matsuura S, 757 Pédespan J-M, 371182 Saito S, 435 Matthews CD, 75 Peguero E, 586 Salanova V, 16 Mattson RH, 7, 457, 1152 Pelkonen O, 241, 810 Salomon ME, 334 Maxwell RE, 130 Pelzl G, 522 Samson Y, 447 Maytal J, 831 Perrine K, 851, 1089 Sancesario G, 990 McCarthy G, 905 Perrone BL, 649 Sander JWAS, 1187 McLin WM, 957 Perucca E, 627 Sanders PT, 1138 McLoughney J, 75 Petroff OAC, 457 Sasa M, 938 McNutt M, 29 Peyster RG, 93 Sass KJ, 7, 851 Meador K, 1089 Pflaster NL, 943 Satishchandra P, 429 Meinardi H, 440 Philippon J, 447 Sato S, 733 Mengel HB, 605 Pichini S, 384 Savic I, 1225 Merboldt KD, 1215 Pienimaki P, 241 Sayal A, 600 Mercuri NB, 990, 997 Pilke A, 262, 817 Saykin AJ, 662, 1071 Mervaala E, 262, 817 Pillai A, 1126 Schapel GJ, 75 Meyerson LR, 93 Pisani A, 990, 997 Schaul N, 831 Minotti L, 1206 Plouin P, 1017 Scheuer ML, 1131 Miyamoto A, 1161 Pokorny J, 543 Scheyer RD, 522, 1152 Montpied P, 911 Poupaert JH, 559 Schmidt R, 946 Morales A, 349 Pradhan N, 416 Schiiler P, 79 Morrell MJ, 355, 1033 Pranzatelli MR, 783 Schultz L, 174 Morris HH, 16 Prensky AL, 1050 Schulz H-U, 255 Moshé SL, 179, 636, 960, 1203 Prevett MC, 113, 592 Schiirer M, 255 Murata R, 757 Prevost J, 922 Schwartzkroin PA, 543 Murialdo G, 360 Ptachewich Y, 179, 636 Seidenberg M, 137 Murphy CC, 866 Pulliainen V, 1195 Seino M, 728, 837, 1084 Mustonen JN, 810 Punal JE, 471 Seitz RJ, 207 Myllyla VV, 366, 676, 810 Purdy P, 58 Selwa LM, 1164 Pusakulich R, 480 Semah F, 447 Nakai H, 644 Serikawa T, 938 Naquet R, 101 Quatrale R, 224 Sgro V, 1206 Nashef L, 1187 Shafrir Y, 1050 Naugle RI, 857 Rabinowicz AL, 475, 513, Shankar S, 429 Nelson PK, 851 1237 Shapiro ED, 334 Niedermeyer E, 516 Radtke RA, 899 Sharbrough FW, 230, 692 Nishio K, 435 Raffel C, | Shaywitz BA, 270 Noachtar S, 207 Rajput A, 29 Shen DD, 772 Néldner M, 983 Ramsay RE, 580 Shende AC, 831 Notarfrancesco A, 1131 Randolph C, 480 Shewmon DA, 873 Nousiainen U, 262, 817 Rankin G, 480 Shigematsu H, 728, 837 Novelly RA, 7 Rapport RL, 772 Shin C, 692 Raroque HG, Jr., 58 Shinnar S, 179, 334, 636, O’Connor MJ, 662, 722 Raucci U, 423 1203 Oestreich LJ, 671 Rautio A, 810 Shorvon SD, 1187, 1233 Offenbacher H, 946 Reivich M, 722 Shouse MN, 290 Ogunyemi AO, 52 Renier WO, 440, 843 Sidenvall R, 572 Ohtahara S, 658 Repo M, 366 Simpkins F, 388 Ohtsuka Y, 658 Ricci S, 342 Singh A, 798 Ojala M, 1118 Richter A, 255 Siniscalchi A, 404 Ojemann GA, 772 Riekkinen P, 262, 817 Sisodiya SM, 1233 Oka E, 658 Rise M, 63 Skolnick BE, 156 Oki J, 1161 Riva E, 1206 Slater JD, 580 Olivier A, 697 Robain O, 1017 Smith GG, 301 Ortiz J, 636 Robinson LJ, 1071 Smith JR, 892 Osumi AK, 899 Rocca WA, 327, 575 Smith JS, 899 Ozcan O, 600 Rodin E, 1078 Smith SJM, 1233 Rodriguez-Nunez A, 471 Smith TD, 475 Pacifici R, 384, 423 Rodriguez-Segade S, 471 So EL, 230, 692 Pakarinen AJ, 366, 676, 810 Rogawski MA, 566 Solinas GP, 360 Paladin AV, 1058 Roger J, 883 Sommerville KW, 164 Pannell LK, 566 Roine RO, 1241 Soria ED, 736 Paolino E, 224 Roland P, 1225 Spencer DD, 7, 371, 522, 851, Papacostas S, 1131 Rondouin G, 973 905 Epilepsia, Vol. 36, No. 12, 1995 1258 AUTHOR INDEX Spencer SS, 7, 236, 522, 905 Ticku MK, 983 Vigevano F, 342, 687 Sperber EF, 960 Tien RD, 899 Vital A, 37 Sperling M, 682 Tiihonen M, 1118 Vries JK, 508 Sperling MR, 156, 662, 722, Tishler DM, 1 1071 Tokumitsu A, 1161 Wada JA, 410, 1142 Stables JP, 559 Tola MR, 224 Wada Y, 290 Stafiniak P, 1071 Torelli D, 687 Walczak TS, 633, 1131 Stecker MM, 214 Towfighi J, 396 Walker MC, 1233 Stefan H, 79 Trabazo S, 471 Waltimo O, 1118 Stefani A, 990, 997 Treiman DM, 214 Wang Z, 196 Stertz B, 1105 Trenerry MR, 230, 692 Weaver DF, 494 Stollberger R, 946 Trevathan E, 866 Weinand ME, 522 Strelow DC, 230 Tsuchimochi H, 1142 Weinberg KI, | Stiibgen J-P, 316 Tuchman L, 270 West SE, 531 Subramaniam S, 566 Tuomisto L, 276 Westerberg C-E, 712 Sudha S, 416 Tuunainen A, 262, 817 Westerberg G, 712 Suisse G, 281 Westerveld M, 851 Sullivan CM, 270 White S, 1105 Ujihara H, 938 Sum JM, 1033 Wiese HJ, 1003 Uludag B, 524 Sundaresan S, 371 Williams DT, 1131 Uozumi T, 938 Sussman NM, 93, 164, 1111 Williamson PD, 7 Uyakul D, 566 Suzdak PD, 612 Wilson JF, 1003 Swartz BE, 388 Winsky L, 911 Szekeres V, 712 Vachon L, 1111 Witte OW, 207 Szymusiak R, 290 Vahakangas K, 241 Wolf A, 824 Valimaki M, 1118 Wolf SM, 1203 Tabuteau H, 371 Vallée J-P, 559 Wong PKH, 1025 Takahashi S, 1161 Vamecgq J, 559 Wszolek ZK, 108 Takahashi Y, 728, 837, 1084 VanLandingham KE, 899 Wyler AR, 137, 480 Takano K, 644 van Lier H, 440 Wyllie E, 16, 1170 Talwar D, 151 van Luijtelaar ELJM, 86 Tanaka T, 644 Van Ness P, 16 Xu SG, 960 Tancredi V, 404 Vannucci RC, 396 Tanindi S, 600 Van Paesschen W, 146 Yagi K, 728, 837, 1084 Tartara A, 360 Vari RC, 649 Yamaguchi S, 566 Tate E, 783 Varosanec S, 946 Yarrington JT, 93 Tatum WO, 214 Velasco AL, 63 Yeargin-Allsopp M, 866 Tennis P, 29 Velasco F, 63 Yokochi K, 435 Thadani VM, 7 Velasco M, 63 Yonemasu Y, 644 Theodore WH, 733, 1105 Velisiek L, 179, 636 Yusuf FH, 831 Thomas P, 281 Velisikova J, 179, 636 Thompson J, 1078 Verhulst SJ, 349 Zanca M, 1041 Thorell JO, 1225 Vickrey BG, 1089 Zuccaro P, 384, 423 UNITED STATES Statement of Ownership, Management, and Circulation Bead postat service. Requires by Epilepsia, 36(12):1259-1267, 1995 Lippincott—Raven Publishers, Philadelphia © International League Against Epilepsy Subject Index Absence epilepsy. See Epilepsy. Aspartame, and seizure susceptibility, 270 Acetylcholinesterase, carbamazepine effects, 416 Assay, automated, phenytoin, near-patient rapid assay, 1152 ACTH, and neonatal seizures induced by corticotropin-releasing ATPase, Na,K-, hippocampal, in temporal lobe epilepsy, 371 hormone, 174 Atrial natriuretic peptide, in recurrent seizures, 649 ADCI (5-aminocarbonyl-10,1 1-dihydro-SH-dibenzocyclohepten- Auras, olfactory, in epilepsy and temporal lobe resection, 531 5,10-imine) pharmacol-inetics, 566 Adenosine receptors, caffeine and seizure susceptibility, 743 Baboon, cingulate kindling, 1142 Afterdischarges, pentobarbital effects during amygdala kindling, Bay K 8644 in nonconvulsive epilepsy, L-type calcium channel 757 modulation, 86 Age factors Behavior CNS trauma, and acute symptomatic seizures, 327 GABA uptake inhibitor tiagabine effects, 612 complex partial seizures of temporal lobe origin, in children, 1173 gabapentin toxicity, in children, 1203 GABA agents and flurothy] seizures, 636 hypoxia/ischemia effects on bicuculline-induced seizures, 396 GABA, agonist effects in substantia nigra, 960 ictal contralateral paresis in complex partial seizures, 671 verbal memory change after temporal lobectomy, 137 in Northern epilepsy syndrome, 792 Alanine aminotransferase, during vigabatrin treatment, 804 prolonged diffuse spike-wave complex, 210 4-Amino-N-(2,6-dimethylphenyl)phthalimide, comparison with social, and spatial memory, in limbic epilepsy, 973 prototype antiepileptic drugs, 559 Benzodiazepine/GABA, receptors Amnesia binding, in absence seizures, 592 global, after temporal lobectomy, hippocampal cooling, 892 measurement with flumazenil and PET, in absence epilepsy, 113 Tryggve Andersen: Epileptic Hallucinations in the 1890s, Fact Birth cohort, unprovoked seizures, 575 or Fiction?, 308 Blood-brain barrier, valproate unsaturated metabolites, 772 Amobarbital, intracarotid, predictor of memory change after Blood flow, cerebral, in spike-wave discharges, 156 temporal lobectomy, 857 Book Reviews Amygdala. neurocytoma in refractory epilepsy, 1237 The Brainstorms Companion: Epilepsy in our View, 319 Amygdala kindling Epilepsy Explained, 627 effect of kindling of interpeduncular nucleus, 410 The Epilepsy Handbook: The Practical Management of limbic epilepsy, spatial memory and social behavior, 973 Seizures, Second Edition, 526 paroxysmal microarousals, 290 Epileptogenic and Excitotoxic Mechanisms, 526 and pentobarbital effects on entorhinal tetanic responses and Herbal Medicines Used Against Epilepsy in Developing afterdischarges, 757 Countries, 627 sensitivity to adverse effects of antiepileptic drugs, 763 Imitator of Epilepsy, 319 Angelman syndrome, EEG pattern, 1206 Infantile Spasms and West Syndrome, 843 Announcements, 111, 217, 321, 427, 528, 629, 740, 845, 950, An Introduction to Clinical Neurology, Pathophysiology, 1061, 1166 Diagnosis and Treatment, 842 Antiepileptic drugs Medical Dictionary in Six Languages, 527 for absence seizures in tremor rat, 938 Motor Development in Children, 526 carbamazepine. See Carbamazepine. Occipital Seizures and Epilepsies in Children, 216 development of, felbamate monotherapy, 1105 Review of Cerebral SPECT Imaging, 842 intractability, migrating partial seizures, in infants, 1017 Status Epilepticus. Its Clinical Features and Treatment in ion channel-modulating FMRFamide tetrapeptide, 494 Children and Adults, 844 long-term, and thyroid status, 1118 Brain MDRI gene expression in brain, in intractable epilepsy, | acetylcholinesterase and monoamine, carbamazepine effects, monotherapy or polytherapy, 440 416 multiple, dose frequency and dose interval compliance, 1111 calbindin D-28k and calretinin mRNA, in genetically epilepsy- oculogyric crisis with carbamazepine, 1158 prone rats, 911 and ovulatory function in epilepsy, 355 cerebral unilateral heterotopia, and epilepsy, in monozygotic phenytoin, near-patient rapid assay, 1152 twins, 1155 prototype, and 4-amino-N-(2,6-dimethylpheny])phthalimide, cortical dysplasia, nonphotosensitive video game-induced 559 partial seizures, 837 sensitivity to adverse effects, effects of amygdala kindling, cortical lesions, in motor partial seizures and lenticulostriate 763 infarcts, 465 and sudden unexplained death, 29 GABA, glutamate, and glutamine, vigabatrin effects, 457 and tamoxifen interaction, 513 gray or white matter, PLEDS localization, 58 trace elements. glutathione peroxidase, and superoxide injury, neuron-specific enolase after nonconvulsive status dismutase, 609 epilepticus, 475 valproate, magnesium effects in hippocampus, 404 intramyelinic edema induced by vigabatrin, detection by MRI, 93 withdrawal MDRI1 gene expression, in intractable epilepsy, | CNS trauma, and acute symptomatic seizures, 327 mesiotemporal atrophy, delta activity as marker of epileptogenic lateralization of event-related potentials, 262 focus, 122 spectral EEG, 817 MRI and spectroscopy, focal status epilepticus, 946 Antipyrine, and carbamazepine metabolism in placenta, 241 neurocytoma, refractory epilepsy, 1237 Anxiety, self-viewing of seizures, 1138 tumors, high-dose tamoxifen interaction with antiepileptic Aphasia, language before and after temporal lobectomy, 1071 drugs, 513 Appalachia, public attitudes on children with epilepsy, 1003 valproate unsaturated metabolites, 772 Apraxia, acquired epileptiform opercular syndrome, comparison Brainstem, kindling of interpeduncular nucleus, and subsequent with Landau-Kleffner syndrome, 1050 amygdala kindling, 410 1260 SUBJECT INDEX Caffeine, neonatal exposure, and seizure susceptibility in adults, 743 Chromosomal disorders, 4p- syndrome, EEG pattern, 1206 Calbindin D-28k and calretinin mRNA, brain, in genetically Cingulate cortex kindling, in baboon, 1142 epilepsy-prone rats, 911 Circadian rhythm, melatonin release in epilepsy, 75 Calcification, intracerebral, after depth electrode implantation, 508 Classification Calcium absence epilepsies, 1182 channels, L-type modulation in nonconvulsive epilepsy, 86 international, childhood epilepsies, 658 high voltage-activated currents, GP 47779 effects, 997 neocortical temporal lobe epilepsy, 633 Carbamazepine i Clinical trials in epileptic men, 366 aspartame and seizure susceptibility, 270 injectable aqueous, complex with 2-hydroxypropyl-B- felbamate monotherapy, 1105 cyclodextrin, comparison with glycofurol-based, 255 multiple antiepileptic drugs, dose frequency and dose interval and learning, memory, acetylcholinesterase and brain compliance, 1111 monoamines, 416 progressive myoclonus epilepsy, 5-hydroxytryptophan effects, long-term monotherapy, cognitive effects, 1195 783 long-term therapy, and thyroid status, 1118 vigabatrin tolerability in children with refractory partial and menstrual disorders, 676 seizures, 687 neurotoxicity, effects of amygdala kindling on sensitivity to, 763 Clobazam in long-term epilepsy treatment, responders with and oculogyric crisis, 1158 without tolerance, 798 vs. oxcarbazepine, thyroid and myocardial function, 810 Cognitive function placental metabolism, 241 and long-term phenytoin and carbamazepine monotherapy, 119 salivary, in home monitoring, 72 and vigabatrin dosages, 164 and trace elements, glutathione peroxidase, and superoxide Compliance, multiple antiepileptic medications, 1111 dismutase, 600 Computed tomography (CT) Cat, paroxysmal microarousals in amygdala kindling, 290 depth electrode implantation, and intracerebral calcification, 50 Catatonia mimicking nonconvulsive status epilepticus, 943 Northern epilepsy syndrome, 792 Central nervous system trauma, acute symptomatic seizures, 327 PLEDS localization in gray or white matter, 58 Centromedian thalamic nucleus, electric stimulation, 63 Computer screens, photosensitive occipital lobe seizures, 883 Cerebellum, crossed diaschisis, and recurrent focal seizures, 316 Construct validity, quality of life in epilepsy inventory, 1089 Cerebral blood flow, in spike-wave discharges, 156 Convulsions Cerebrospinal fluid (CSF) See also Seizures. histamine, and febrile convulsions, 276 febrile, and histamine in CSF, 276 purine metabolites and pyrimidine bases after febrile febrile, CSF purine metabolites and pyrimidine bases, 471 convulsions, 471 paroxysmal microarousals, in amygdala kindling, 290 Chemosensory event-related potentials, 79 Cooling of hippocampus, global amnesia after temporal Chicken, Fayoumi mutant, development of epilepsy, 101 lobectomy, 892 Children and infants Cortical dysplasia, suppression-bursts in epileptic encephalopathy absence epilepsies, classification, 1182 37 age factors, complex partial seizures of temporal lobe origin, Corticostriatal system, oxcarbazepine metabolite GP 47779 1173 effects, 990, 997 asymmetric hypsarrhythmia, 41 Corticotropin-releasing hormone, neonatal seizures induced by, epilepsy prevalence in 10-year-olds, 866 ACTH effects, 174 epileptic encephalopathy with suppression-bursts and cortical Cytochrome oxidase, hippocampal, in temporal lobe epilepsy, 37 dysplasia, 37 Cytokines in blood mononuclear cells, in epilepsy, 384 epileptic spasms in older children, persistence beyond infancy, 151 Death, sudden unexplained gabapentin toxicity, and behavioral changes, 1203 and learning difficulties in epilepsy, 1187 hemimegalencephaly, 1215 mesial vs. neocortical temporal lobe epilepsy, 662 histamine in CSF, and febrile convulsions, 276 resulting from seizures, 25 identification of localized-onset seizures, 1170 seizures treated with antiepileptic drugs, 29 immune response to vigabatrin treatment, 423 Delta activity in mesiotemporal atrophy, marker of epileptogenic infantile spasms, asymmetric and asy‘ichronous, 873 focus, 122 international classification of childhood epilepsy, 658 Deprenyl deuterium, PET in temporal lobe epilepsy, 712 learning difficulties, and sudden death in epilepsy, 1187 Dermorphin, seizures triggered by, 922 migrating partial seizures, 1017 Deuteranomaly, wavelength specificity in photoparoxysmal neonatal seizures responses, idiopathic generalized epilepsy, 1084 prolactin levels, 682 Development spatial and temporal characteristics, 1009 of epilepsy, in Fayoumi mutant chicken, 101 Northern epilepsy syndrome, 792 flurothyl-induced seizures, MK-801 and phenytoin effects, 179 occipital paroxysmal discharges suppressed by eye opening, 52 migrating partial seizures, in infants, 1017 phenobarbital and phenytoin interactions with carbamazepine, seizure semiology, 1170 249 Developmental disabilities, epilepsy prevalence in 10-year-olds, prolactin, and neonatal seizures, 349 866 public attitudes on epilepsy, 1003 Diaschisis, cerebellar, and focal seizures, 316 reflex myoclonic epilepsy, relation to startle reaction, 342 Diazepam neurotoxicity, effects of amygdala kindling on with refractory partial seizures, vigabatrin tolerability, 687 sensitivity to, 763 salivary carbamazepine, in home monitoring, 72 Dizocilpine binding to ADCI, 566 seizures in acute lymphoblastic leukemia, 831 Dog self-induced photogenic seizures, in myoclonic epilepsy, 728 injectable aqueous carbamazepine, complex with 2- spike complexity, and relative epileptogenicity, 1078 hydroxypropyl-B-cyclodextrin, comparison with trace elements, glutathione peroxidase, and superoxide glycofurol-based, 255 dismutase, in antiepileptic drug therapy, 600 MRI detection of vigabatrin-induced intramyelinic edema in very-low-birthweight infants, incidence of epilepsy, 435 brain, 93 Epilepsia Vol. 36, No. 12, 1995 SUBJECT INDEX Dosage neonatal seizures ADCI, acute and chronic treatment, 566 prolactin role, 349 frequency and interval compliance, multiple antiepileptic drugs, spatial and temporal characteristics, 1009 1111 Northern epilepsy syndrome, 792 monotherapy or polytherapy, 440 occipital lobe epilepsy tiagabine pharmacokinetics, 605 misdiagnosis as migraine, 1233 valproate, daily doses or controlled release preparations, 929 paroxysmal discharges suppressed by eye opening, 52 of vigabatrin, effects on cognitive function and quality of life, opercular myoclonic-anarthric status epilepticus, 281 164 palatal tremor presenting as epilepsia partialis continua, 207 vigabatrin tolerability in children with refractory partial panic attacks seizures, 687 or epilepsy relapse, 48 Drug interactions in parietal lobe seizures, 824 phenobarbital and phenytoin with carbamazepine, in epileptic paroxysmal microarousals, in amygdala kindling, 290 children, 249 prolonged diffuse spike-wave complex, without behavior or tamoxifen and antiepileptic drugs, 513 intellectual changes, 210 Dystonia, in temporal lobe seizures, 1065 psychogenic nonepileptic seizures, outcome analysis, 1131 reflex myoclonic epilepsy, and startle reaction in infants, 342 Echocardiography scalp/sphenoidal, ictal recording, and localization of oxcarbazepine effects, 810 epileptogenic region, 1033 thyroid status, and long-term antiepileptic drugs, 1118 seizures of supplementary sensorimotor area, in children, 1025 Edema, intramyelinic, vigabatrin-induced, detection by MRI, 93 spectral, during discontinuation of antiepileptic drugs in partial Editorials epilepsy, 817 Developmental Aspects of Seizure Semiology: Problems in spike complexity, and relative epileptogenicity, 1078 Identifying Localized-Onset Seizures in Infants and status epilepticus, neuroprotective effects of ketamine, 186 Children, 1170 tremor rat, antiepileptic drugs for absence seizures, 938 Hormonal Changes in Epilepsy, 323 zonisamide effects on kainic acid-induced limbic seizures, 644 Neocortical Temporal Lobe Epilepsy: Characterizing the Electron microscopy, granule cell circuitry in epileptic Syndrome, 633 hippocampus, 543 Public Perceptions About Epilepsy, 957 Electrophysiology Electric stimulation, centromedian thalamic nucleus, 63 familial progressive myoclonus epilepsy, 429 Electrocortiography GP 47779 effects on corticostriatal system, 990, 997 homocysteine-induced seizures, during ontogenesis, 750 granule cell circuitry in epileptic hippocampus, 543 hypoxia/ischemia effects on bicuculline-induced seizures, 396 pentobarbital effects on entorhinal tetanic responses and and temporal lobe epilepsy, relation to MRI and operative afterdischarges during amygdala kindling, 757 outcome, 692 zonisamide effects on kainic acid-induced limbic seizures, 644 Electrodes Emergency medical service depth injury and death from seizures, 25 bilateral hippocampal atrophy in medial temporal lobe propofol in prehospital treatment of convulsive status epilepsy, 905 epilepticus, 1241 and intracerebral calcification, 508 Encephalopathy in temporal lobe epilepsy, 230 epileptic, with suppression-bursts and cortical dysplasia, 37 subdural, hematoma-related seizures, 733 seizures in neonates, prolactin levels, 682 Electroencephalogram (EEG) Entorhinal cortex tetanic responses, pentobarbital effects during acquired epileptiform opercular syndrome, comparison with amygdala Landau-Kleffner syndrome, 1050 kindling, 757 amygdala kindling, effect of kindling of interpeduncular Epidemiology nucleus, 410 acute symptomatic seizures, 327 aspartame and seizure susceptibility, 270 childhood epilepsy, international classification, 658 asymmetric hypsarrhythmia, 41 epilepsy prevaience in 10-year-olds, 866 catatonia mimicking nonconvulsive status epilepticus, 943 ethnic and geographic factors in classic photoparoxysmal cerebral blood flow during spike-wave discharges, 156 response in EEG, 219 classic photoparoxysmal response, ethnic and geographic infantile spasms, 572 factors, 219 risk factors for idiopathic generalized seizures, 224 closed-circuit television, psychogenic elaboration of partial sudden unexplained death, antiepileptic drug treatment, 29 seizures, 1126 unprovoked seizures, secular trends and birth cohort effects, 575 delta activity as marker of epileptogenic focus, in Epilepsia partialis continua, palatal tremor of cortical origin, 207 mesiotemporal atrophy, 122 Epilepsy epilepsy development, in Fayoumi mutant chicken, 101 absence epilepsy prevalence in 10-year-olds, 866 benzodiazepine/GABA, receptors measured with flumazenil epileptic spasms in older children, persistence beyond infancy, and PET, 113 151] classification and prognosis, | 182 after epilepsy surgery, 236 acquired epileptiform opercular syndrome, comparison with false lateralization with FDG PET, in temporal lobe epilepsy, Landau-Kleffner syndrome, 1050 722 carbamazepine treatment, and menstrual disorders, 676 in 4p- syndrome, 1206 and cerebral unilateral heterotopia, in monozygotic twins, 1155 frequency in intracerebral seizures, 697 childhood, international classification, 658 frontal lobe seizures, 16 clobazam in long-term treatment, responders with and without infantile spasms, asymmetric and asynchronous, 873 tolerance, 798 intracranial, and epilepsy surgery, 7 cytokine production in blood mononuclear cells, 384 mesial vs. neocortical temporal lobe epilepsy, 662 development, in Fayoumi mutant chicken, 101 migrating partial seizures, in infants, 1017 encephalopathy with suppression-bursts and cortical dysplasia, motor partial seizures and lenticulostriate infarcts, 465 37 Epilepsia, Vol. 36, No. 12, 1995 1262 SUBJECT INDEX familial progressive myoclonus, 429 Fear, panic attacks in parietal lobe seizures, 824 frontal lobe Febrile seizures FDG-PET sensitivity, 388 CSF purine metabolites and pyrimidine bases, 471 flumazenil PET, 1225 first episode, risk factors, 334 granule cell circuitry in hippocampus, 543 and histamine in CSF, 276 hemimegalencephaly, magnetic resonance spectroscopy, 1215 Felbamate monotherapy, and seizure rate, 1105 hormonal changes, 323 Filters, optical, self-induced photogenic seizures, in myoclonic ictal recording, and localization of epileptogenic region, epilepsy, 728 scalp/sphenoidal EEG, 1033 Flumazenil idiopathic generalized, wavelength specificity in benzodiazepine/GABA, receptors in absence epilepsy, 113 photoparoxysmal responses, 1084 PET, frontal epileptogenic regions, 1225 immune response to vigabatrin treatment, 423 Flurothyl intractable, MDR/ gene expression in brain, | and NBQX block of perinatal hypoxic seizures, 966 learning difficulty, and sudden death, 1187 seizures, age-dependent effects of GABA agents, 636 limbic, spatial memory and social behavior, 973 seizures, MK-801 and phenytoin effects, 179 male hormones, and pituitary function, 360, 366 FMRFamide tetrapeptide, ion channel-modulating, 494 melatonin release, 75 4p- syndrome, EEG pattern, 1206 monotherapy or polytherapy, 440 Frequency analysis, EEG in intracerebral seizures, 697 nonconvulsive, L-type calcium channel modulation, 86 Frontal lobe seizures occipital lobe, misdiagnosis as migraine, 1233 electroclinical syndromes, 16 ovulatory function, 355 Fj FDG-PET sensitivity, 388 partial flumazenil PET, 1225 alanine aminotransferase decrease during vigabatrin of supplementary sensorimotor area, in children, 1025 treatment, 804 spectral EEG during drug discontinuation, 817 GABA (y-aminobutyric acid) phenobarbital and phenytoin interactions with carbamazepine, benzodiazepine/GABA, receptors 249 binding in absence seizures, 592 photosensitive occipital lobe, 883 measurement with flumazenil and PET, 113 prevalence in 10-year-old children, 866 GABA, agonist effects in substantia nigra, age factors, 960 progressive myoclonus, response to 5-hydroxytryptophan, GABA, receptors, losigamone and isomers effects, 983 783 receptors, and flurothyl seizures, age factors, 636 public attitudes, 488, 957, 1003 uptake inhibitor tiagabine quality of life inventory, 1089 neurochemical and behavioral effects, 612 reading, ictal HMPAO-SPECT, 1161 pharmacokinetics of, 605 reflex myoclonic, in infants, relation to startle reaction, 342 vigabatrin effects in brain, 457 refractory, cerebral neurocytoma, 1237 Gabapentin toxicity, behavioral changes in children, 1203 relapse, or panic attacks, 48 Gene expression self-viewing of seizures, 1138 brain calbindin D-28k and calretinin mRNA, in genetically spasms, in older children, persistence beyond infancy, 151 epilepsy-prone rats, 911 status epilepticus. See Status epilepticus. MDR1, in brain, in intractable epilepsy, | surgery. See Lobectomy, temporal; Neurosurgery. Surgery Genetics without intracranial EEG, 7 epidemiology of infantile spasms, 572 temporal lobe epilepsy development, in Fayoumi mutant chicken, 101 chemosensory event-related potentials, 79 familial progressive myoclonus epilepsy, 429 depth electrodes, 230 Northern epilepsy syndrome, 792 electrocortiography, relation to MRI and operative outcome, risk factors for idiopathic generalized seizures, 224 692 tiagabine effects, 612 false lateralization with FDG PET, 722 Geographic factors, in classic photoparoxysmal response in EEG, ipsilateral head turning and dystonia, 1065 219 medial, bilateral hippocampal atrophy, 905 Geometry optimization, ion channel-modulating FMRFamide PET with deuterium-deprenyl, 712 tetrapeptide, 494 resection, effect on olfactory function, 531 Gliosis visual learning, selective reminding and delayed recall, 704 hemimegalencephaly, 1215 in twentieth century literature, 1058 PET with deuterium-deprenyl, in temporal lobe epilepsy, 712 valproate treatment, daily doses or controlled release Glossopharyngeal muscles, opercular myoclonic-anarthric status preparations, 929 epilepticus, 281 in very-low-birthweight infants, 435 Glutamate vigabatrin dosage effects on cognitive function and quality of and unit discharges in CA1 area of hippocampus, 196 life, 164 vigabatrin effects in brain, 457 Erratum, Physiologic and Morphologic Characteristics of Granule Glutamine, vigabatrin effects in brain, 457 Cell Circuitry in Human Epileptic Hippocampus, 1064 Glutathione peroxidase, and antiepileptic drug therapy, 600 Estrogens Gonadotropins in epileptic men, 360 carbamazepine treatment, and menstrual disorders, 676 GP 47779 in epilepsy, 323 and corticostriatal synaptic transmission, 990 Ethnic factors, classic photoparoxysmal response in EEG, 219 and high voltage-activated calcium currents, 997 Event-related potentials Granule cell circuitry, in epileptic hippocampus, 543 auditory, lateralization during discontinuation of antiepileptic medication, 262 Hallucinations, Tryggve Andersen: Epileptic Hallucinations in the chemosensory, in temporal lobe epilepsy, 79 1890s, Fact or Fiction?, 308 Eye opening, and occipital paroxysmal discharges, 52 Head injuries, from seizures, 25 Head turning, ipsilateral, and dystonia, in temporal lobe seizures, Family history, risk factor for first febrile seizure, 334 1065 Epilepsia, Vol. 36, No. 12, 1995 SUBJECT INDEX Health Surveys Kainic acid public attitudes on children with epilepsy, 1003 limbic epilepsy, spatial memory and social behavior, 973 quality ofl ife in epilepsy inventory, 1089 limbic seizures, zonisamide effects, 644 Hematoma seizures, during subdural electrode monitoring, 733 seizure susceptibility, in DBA/2J and C57BL/6J mice, 301 Hemimegalencephaly, magnetic resonance spectroscopy, 1215 Ketamine, neuroprotective effects, in status epilepticus, 186 Heterotopia, cerebral unilateral, and epilepsy, in monozygotic Kidney failure twins, 1155 in HIV infections, and new-onset seizures, 146 High performance liquid chromatography with recurrent seizures, 649 carbamazepine metabolism in placenta, 241 Kindling histamine in CSF, and febrile convulsions, 276 amygdala Hippocampus paroxysmal microarousals, 290 anticonvulsant effects of valproate, magnesium role, 404 pentobarbital effects on entorhinal tetanic responses and bilateral atrophy, in medial temporal lobe epilepsy, 905 afterdischarges, 757 epileptic, granule cell circuitry, 543 sensitivity to adverse effects of antiepileptic drugs, 763 fast spin-echo MRI, neuronal density in temporal lobectomy cingulate cortex, in baboon, 1142 patients, 899 interpeduncular nucleus, and subsequent amygdala kindling, 410 Na,K-ATPase, cytochrome oxidase, and total protein, in temporal lobe epilepsy, 371 Lafora disease, 5-hydroxytryptophan effects, 783 thermal inactivation, and global amnesia after temporal Landau-Kleffner syndrome, comparison with acquired lobectomy, 892 epileptiform opercular syndrome, 1050 unit discharges in CA1 area, effects of glutamate, NMDA, Language potassium, and hypoxia, 196 after temporal lobectomy without mapping of cortical function, Histamine in CSF, and febrile convulsions, 276 130 Histochemistry before and after temporal lobectomy, 1071 granule cell circuitry, in epileptic hippocampus, 543 Lateralization hippocampal Na,K-ATPase, cytochrome oxidase, and total false, FDG PET of temporal lobe epilepsy, 722 protein, in temporal lobe epilepsy, 371 seizures, and Wada test memory disparities, 851 Historical Notes Learning The Medical-Moral Account on Epilepsy by Pedro de Horta: carbamazepine effects, 416 A Historical Review, 736 difficulties, and sudden death in epilepsy, 1187 Tryggve Andersen: Epileptic Hallucinations in the 1890s, Fact visual, selective reminding and delayed recall, in temporal lobe or Fiction?, 308 epilepsy, 704 Homocysteine seizures, during ontogenesis, 750 Lenticulostriate infarcts, motor partial seizures, 465 Hormones Letters to the Editor, 214, 522, 524; 1164 in epilepsy, 323, 355 Leukemia, lymphoblastic, seizure treatment, 831 male, and pituitary function in epilepsy, 360, 366 Limbic system, epilepsy and temporal lobe resection, effects on and olfactory function in epilepsy, 531 olfactory function, 531 Human immunodeficiency virus (HIV) infections, new-onset Literature seizures and metabolic abnormalities, 146 Tryggve Andersen: Epileptic Hallucinations in the 1890s, Fact 2-Hydroxypropyl-B-cyclodextrin, carbamazepine complex, or Fiction?, 308 tolerability and pharmacokinetics, 255 twentieth century, epilepsy portrayals, 1058 5-Hydroxytryptophan, in progressive myoclonus epilepsy, 783 Lobectomy, temporal Hypersomnolence, episodic, due to seizures, 108 age factors in verbal memory changes, 137 Hypothalamopituitary axis, in epilepsy, 323 fast spin-echo MRI of hippocampal volume, 899 Hypoxia global amnesia, and hippocampal cooling, 892 and ischemia, bicuculline-induced seizures, behavioral and intracarotid amobarbital as predictor of memory change, 857 electrocortical effects, 396 language before and after, 1071 perinatal seizures, NBQX block of, 966 lateralization of event-related potentials during drug and unit discharges in CA1 area of hippocampus, 196 discontinuation, 262 Hypsarrhythmia, asymmetric, EEG and radiology, 41 and olfactory function, 531 without stimulation mapping, language function, 130 Ictal recording Wechsler Adult Intelligence Scale-Revised in evaluation, 480 and localization of epileptogenic region, scalp/sphenoidal EEG, Losigamone and isomers, effects on GABA, receptors, 983 1033 Luteinizing hormone in epileptic men, 360 SPECT, in reading epilepsy, 1161 Immune response, vigabatrin treatment in epileptic children, Magnesium 423 extracellular, and valproate effects in hippocampus, 404 Immunoassay, phenytoin, near-patient rapid assay, 1152 in HIV infections, and new-onset seizures, 146 Incontinence, in psychogenic seizures, 586 Magnetic resonance imaging (MRI) Infections, HIV, new-onset seizures and metabolic abnormalities, bilateral hippocampal atrophy in medial temporal lobe epilepsy, 146 905 Infertility, ovulatory function in epilepsy, 355 crossed cerebellar diaschisis, and recurrent focal seizures, 316 Injury delta activity as marker of epileptogenic focus, in and death, from seizures, 25 mesiotemporal sclerosis, 122 self-inflicted, in psychogenic seizures, 586 depth electrodes in temporal lobe epilepsy, 230 Intellectual factors, prolonged diffuse spike-wave complex, and electrocortiography, in temporal lobe epilepsy, 692 210 epileptic encephalopathy, with suppression-bursts and cortical Interleukins in blood mononuclear cells, in epilepsy, 384 dysplasia, 37 Ischemia fast spin-echo, hippocampal volume, neuronal density in in bicuculline-induced seizures, behavioral and electrocortical temporal lobectomy patients, 899 effects, 396 of focal status epilepticus, 946 tiagabine effects, 612 frontal lobe epilepsy, FDG-PET sensitivity, 388 Epilepsia, Vol. 36, No. 12, 1995 1264 SUBJECT INDEX hemimegalencephaly, 1215 NBQX, and perinatal hypoxic seizures, 966 panic attacks in parietal lobe seizures, 824 Neocortical temporal lobe epilepsy PLEDS localization in gray or white matter, 58 characterization of syndrome, 633 temporal interictal hypometabolism and mesial sclerosis, 447 vs. mesial, 662 temporal lobectomy without EEG, 7 Neurocytoma, cerebral, refractory epilepsy, 1237 vigabatrin effects on GABA, glutamate, and glutamine in brain, Neuroimaging 457 asymmetric hypsarrhythmia, 41 vigabatrin-induced intramyelinic edema in brain, 93 PLEDS localization in gray or white matter, 58 Mapping, stimulation, in temporal lobectomy, language function, Neuron-specific enolase, after nonconvulsive status epilepticus, 130 475 MDRI! gene expression, in brain, in intractable epilepsy, | Neuronal density in temporal lobectomy, fast spin-echo MRI of Melatonin in active epilepsy, 75 hippocampal volume, 899 In Memoriam, A.Earl Walker: Neurosurgeon, Neuroscientist, and Neuroprotection by ketamine, in status epilepticus, 186 Epileptologist, 516 Neuropsychology Memory age factors in verbal memory changes after temporal lobectomy, carbamazepine effects, 416 137 global amnesia after temporal lobectomy, hippocampal cooling, cognitive effects of long-term phenytoin and carbamazepine 892 monotherapy, 1195 material-specific, intracarotid amobarbital as predictor after language before and after temporal lobectomy, 1071 temporal lobectomy, 857 language function after temporal lobectomy without stimulation spatial, and social behavior, in limbic epilepsy, 973 mapping, 130 verbal, after temporal lobectomy, age factors, 137 nonphotosensitive video game-induced partial seizures, 837 visual learning, selective reminding and delayed recall, in pseudoseizures, induction by intravenous saline, 580 temporal lobe epilepsy, 704 quality of life in epilepsy inventory, 1089 Wada test disparities, and seizure laterality and postoperative temporal lobectomy without EEG, 7 seizure control, 851 Wechsler Adult Intelligence Scale-Revised in evaluation for Mensicual disorders, and carbamazepine, 676 temporal lobectomy, 480 Mental deterioration, Northern epilepsy syndrome, 792 Neurosurgery Mesiotemporal sclerosis See also Lobectomy, temporal delta activity as marker of epileptogenic focus, 122 depth electrode implantation EEG and seizure outcome after epilepsy surgery, 236 and intracerebral calcification, 508 vs. neocortical temporal lobe epilepsy, 662 in temporal lobe epilepsy, 230 and temporal interictal hypometabolism, 447 EEG and seizure outcome, 236 Message from the Editor, 955 and electrocortiography, in temporal lobe epilepsy, 692 Metabolism epileptic encephalopathy with suppression-bursts and cortical and new-onset seizures in HIV infections, 146 dysplasia, 37 temporal interictal hypometabolism and mesial sclerosis, 447 for frontal lobe seizures, 16 Methohexital distribution monitored with HMPAO, SPECT during global amnesia after temporal lobectomy, hippocampal cooling, Wada test, 1041 892 N-Methyl-D-aspartate (NMDA), and unit discharges in CAI area mesial vs. neocortical temporal lobe epilepsy, 662 of hippocampus, 196 seizure laterality, and Wada test memory disparities, 851 Migraine, misdiagnosis of occipital lobe epilepsy, 1233 temporal lobe resection, and olfactory function, 531 Mitochondrial encephalomyopathy, 5-hydroxytryptophan effects, temporal lobectomy without EEG, 7 783 Neurotoxicity MK-801 4-amino-N-(2,6-dimethylphenyl)phthalimide, comparison with and flurothyl-induced seizures during development, 179 prototype antiepileptic drugs, 559 and NBQX block of perinatal hypoxic seizures, 966 of antiepileptic drugs, effects of amygdala kindling on Molecular conformation, ion channel-modulating FMRFamide sensitivity to, 763 tetrapeptide, 494 GABA uptake inhibitor tiagabine, 612 Monitoring, home, of carbamazepine, in saliva, 72 gabapentin, behavioral changes in children, 1203 Monoamines, brain, carbamazepine effects, 416 monotherapy or polytherapy of antiepileptic drugs, 440 Mononuclear cells, blood, cytokine production, 384 Neurotoxins, focal seizures, and crossed cerebellar diaschisis, Morbidity, very-low-birthweight infants, incidence of epilepsy, 43 5 316 Mossy fibers, granule cell circuitry in epileptic hippocampus, 54 3mi Northern epilepsy syndrome, clinical course and medication Mouse effects, 792 ADCI pharmacokinetics, 566 4-amino-N-(2,6- Nucieus, centromedian thalamic, electric stimulation, 63 dimethylphenyl)phthalimide, comparison with prototype antiepileptic drugs, 559 Occipital lobe epilepsy audiogenic seizure, unit discharges in CA1 area of misdiagnosis as migraine, 1233 hippocampus, effects of glutamate, NMDA, potassium, and paroxysmal discharges suppressed by eye opening, 52 hypoxia, 196 photosensitive, 883 DBA/2J and C57BL/6J, seizure susceptibility induced by kainic Oculogyric crisis with carbamazepine, 1158 acid, 301 Ohtahara syndrome, suppression-bursts in epileptic Muscimol, GABA, agonist effects in substantia nigra, age factors, encephalopathy, 37 960 Olfaction Myocardial function, oxcarbazepine effects, 810 chemosensory event-related potentials, in temporal lobe Myoclonus epilepsy, 79 familial progressive epilepsy, 429 epilepsy and temporal lobe resection, 531 4p- syndrome, EEG pattern, 1206 Ontogeny progressive epilepsy, response to 5-hydroxytryptophan, 783 homocysteine-induced seizures, 750 reflex epilepsy, and startle reaction in infants, 342 seizure susceptibility in adults, neonatal caffeine exposure, 743 self-induced photogenic seizures, in infancy, 728 Opercular myoclonic-anarthric status epilepticus, case reports, 281 Epilepsia, Vol. 36, No. 12, 1995

See more

The list of books you might like

Upgrade Premium
Most books are stored in the elastic cloud where traffic is expensive. For this reason, we have a limit on daily download.
DMCA & Copyright: Dear all, most of the website is community built, users are uploading hundred of books everyday, which makes really hard for us to identify copyrighted material, please contact us if you want any material removed.
Copyright @ PDFdrive.to, 2022 | We love our users